health wellbeing oriolakd annual report 2016 oriolakd business environment strategy business area case corporate governance financial statement content oriolakd brief 2 service 18 mission vision 5 healthcare 19 ceo review 6 oriolakd investment 20 industry sector market 8 responsibility 22 strategy target 10 case 24 medicine path 14 board director 26 business area 16 group management team 28 consumer 17 financial statement 31 6 ceo review 20 oriolakd 24 case investment oriolakd business environment strategy business area case corporate governance financial statement 1 oriolakd year 2016 net sale oriolakd unites consumer pharmaceutical company meur unique way oriolakd provides pharmaceutical company effective access market improves consumer wellbeing 16421 16197 16263 16123 15218 ensuring pharmaceutical health product service delivered safe customerfriendly manner net sale 2016 eur 16 billion 12 13 14 15 16 adjusted operating profit meur 611 608 591 investment 2016 pharmacy employee 888 325 2821 370 291 eur million 12 13 14 15 16 oriolakd business environment strategy business area case corporate governance financial statement 2 oriolakd year 2016 oriolakd brief oriolakd finnish stocklisted company operates pharmaceutical health wellbeing product retail wholesale oriolakd solid position consumer service business pharmaceutical market sweden finland baltic country improve people wellbeing ensuring pharmaceutical consumer health product delivered safe customerfriendly manner pharmacy offer expert advice health wellbeing extensive highquality selection product offer operator healthcare sector broad selection service provide effective reliable link pharmaceutical company consumer sweden finland estonia latvia lithuania oriolakd business environment strategy business area case corporate governance financial statement 3 unique position improve people wellbeing net sale eur 16 billion oriolakd year 2016 ensuring pharmaceutical consumer health product deliv ered safe customerfriendly 2821 personnel manner provide effective reliable link pharmaceutical 325 pharmacy company consumer preferred partner nordic country oriolakd operates sweden finland baltic country customer pharmacy hospital pharmacy consumer pharmaceutical company veterinarian grocery dentist public private healthcare oriolakd business environment strategy business area case corporate governance financial statement 4 oriolakd year 2016 big small moment oriolakd business environment strategy business area case corporate governance financial statement improve people wellbeing mission channel health improve people wellbeing ensuring reliable customerfriendly delivery pharmaceutical consumer health product vision oriolakd pharmaceutical channel northern europe want preferred channel northern europe connecting pharmaceutical manufacture consumer providing pharmaceutical manufacturer health consumer product producer reliable access market providing consumer excellent reliable service open work together take initiative take responsibility oriolakd business environment strategy business area case corporate governance financial statement 6 ceo review ceo review oriolakd year 2016 year 2016 first whole year whole service itsystem renewal operated structure set according enköping mölnlycke enlargement project new strategy able improve progressed according plan service customer group realization efficiency logistics process finland new strategy visible also acquisition much improved concentrated finnish digitalization large logistics project distribution espoo second quarter initiative preparing market change customer new need new innovation logistics value chain already clearly visible sweden require u new innovation beginning year finalised ecommerce growing strongly also able acquisition svensk do dose dispensing even better answer customer authori logistics value chain company intergrated new tie higher quality expectation digitalization must faster healthcare business area spring 2016 customer new need require u new inno significant growth potential dose dispensing vations logistics value chain must faster efficient available finland sweden im pleased efficient available customer customer every day easy progress last year addition every day easy clever way demand acquired farenta service company continuous improvement development clever way complement service business first finland procedure coming year hopefully also sweden see video acquired company successfully growing role digital service integrated able offer added established 2016 14 new pharmacy value customer new service developed several new digital service oriolakd business environment strategy business area case corporate governance financial statement 7 ceo review oriolakd year 2016 e l abl av r e stome w u ur c day consumer webstore digital service key development ry area u sweden ecommerce rapidly growing 2016 eve already four per cent total pharmacy sale able grow traded good otc share sale sweden also webstore grew strongly especially final quarter believe new year interesting due increasing competition strong growth ecommerce 2016 lively discussion finland development need pharmacy market light stated argument matter clear much potential development patient safety good level finland important regulate pharmacy operation future least well currently also undisputed fact regulation concerning phar macy ownership make difficult increase efficiency unnecessarily increase retail cost medicine compared nordic country example sweden prof regional availability medicine safeguarded time general availability medicine competition market increased opinion important pharmaceutical distribution whole part solution healthcare reform planning board finland interesting year ahead past year busy new year seems offer many new interesting project want thank customer employee year 2016 hope may together year 2017 least successful eero hautaniemi ceo oriolakd business environment strategy business area case corporate governance financial statement 8 industry sector market industry sector market oriolakd year 2016 operate finnish finland swedish baltic value finnish pharmaceutical market 2016 pharmaceutical wellbeing eur 2205 billion estimated annual growth 2020 approx 1 per cent source ims health product market share pharmaceutical company 58 pharmaceutical wholesaler 2 815 pharmacy finland source medicine pharmacy 24 customer pharmaceutical company association finnish pharmacy euro state 16 health wellbeing product producer pharma 93 per cent customer happy service cies hospital healthcare operator pharmacy whole source association dentist vet well consumer finnish pharmacy medicine allowed sold pharmacy pharmaceutical sector carefully regulated nicotine replacement therapy product also sold patient medicine safety grocery store important requirement steer operation pharmaceutical must distributed patient sweden safely time regardless circumstance total value swedish pharmaceutical market 2016 sek 41 6 billion estimated annual growth 2020 approx 4 per cent source ims health pharmaceutical company 80 share pharmaceutical wholesaler 3 medicine pharmacy 17 1394 pharmacy sweden source euro state 0 apoteksförening 97 per cent customer happy last visit pharmacy source apoteksförening prescription medicine sold pharmacy part otc product available grocery store oriolakd business environment strategy business area case corporate governance financial statement 9 industry sector market changing oriolakd year 2016 business environment people become interested healthcare changing amount ageing population increasing health living leading growing healthcare need cost offer longer also spending new business opportunity niche service provided public private healthcare money health wellbeing digitalisation consumer becoming technically oriented consumer demanding willing able use expecting service available 247 retail business technology used service available 247 retail becoming increasingly digital electronic service business becoming increasingly digital electronic service becoming necessity becoming new normal pharmaceutical market undergoing radical change increased spending health wellbeing role various operator changing new kind market rising income level enable consumer prioritize health participant emerging consolidation occurring wellbeing people want live healthy life spending market pharmaceutical company specialising focusing health wellbeing increase core business digitalisation impact opera tor need electronic service growing change speciality pharmaceutical growth increasing demand new service demand speciality pharmaceutical hospital amount elderly increasing leading increasing sector growing expensive biomedicine require healthcare need change creating new business opportuni special handling storage transportation unique handling tie public private healthcare sector pharmaceutical new special service small customer group increase oriolakd business environment strategy business area case corporate governance financial statement 10 strategy target strategy changing oriolakd year 2016 business environment oriolakd help consumer enhance wellbeing pharmacy offer expert advice health wellbeing extensive highquality selection product offer extensive range service oper ators healthcare sector sweden finland meet business baltic country unite pharmaceutical company consumer unique way environment challenge provide pharmaceutical company effec tive route market promote people well expanding traditional pharmaceutical distribution service pharmaceutical company retail trade ensuring pharmaceutical consumer health product service delivered safe offering pharmaceutical company single point access nordic pharmaceutical market customerfriendly manner developing online service service business part strategy consumer business offering pharmaceutical service healthcare sector including hospital offering excellent customer experience product assortment improving efficiency enhance competitiveness oriolakd business environment strategy business area case corporate governance financial statement 11 strategy target target oriolakd year 2016 annual eps growth longterm financial target 5 business growth rate market growth annual eps growth 5 per cent without nonrecurring item return capital employed return capital employed 20 per cent 20 adjusted gearing ratio 3060 per cent nonrecourse trade receivables added net debt key focus area 2017 active development digital business successful execution efficiency improving strategic development initiative development healthcare business oriolakd business environment strategy business area case corporate governance financial statement 12 oriolakd year 2016 best moment together oriolakd business environment strategy business area case corporate governance financial statement smooth efficient service offer expert advice health wellbeing extensive high quality product selection kronans apotek pharmacy operator healthcare sector offer broad selection service provide effective reliable link pharmaceutical company sweden finland baltic country improve people wellbeing ensuring pharmaceutical consumer health product important partner delivered safe customerfriendly manner touch pharmaceutical local consumer industry oriolakd business environment strategy business area case corporate governance financial statement 14 medicine path medicine path oriolakd year 2016 manufacturer consumer pharmaceutical distribution requires much expertise skill phase high quality safety requirement concern entire distribution chain medicine path manufacturer consumer go via pharmaceutical wholesaler pharmacy every phase case complete research logistics chain distribution chain important ensure safety make sure pharmaceutical research right medicine right place right time pharmaceutical distributor responsible storing distributing carried finland pharmaceutical pharmacy hospital relevant operator sweden oriola offer pharmaceutical addition distribution pharmaceutical wholesaler also company comprehensive tailored take care information flow ensures safety according authority research logistics service oriola clinical regulation aim everything efficiently speedily supply service cover entire lifespan medicine delivered pharmacy within 24 hour investigational drug offer order availability medicine high level finland pharmaceutical company service sweden importing investigational drug return disposal say anu heikkinen product manager oriolas clinical supply service finland read oriolakd business environment strategy business area case corporate governance financial statement 15 oriolakd year 2016 pharmaceutical medicine path start research development go via pharmaceu research tical wholesaler pharmacy hospital finally patient pharmaceutical development wholesaler specialized storing distributing pharmaceutical product single channel model pharmacy hospital purchase pharmaceutical company product one wholesaler pharmaceutical pharmaceutical manufacturer wholesaler pharmacy public private healthcare dentist consumer patient dose dispensing unit pharmacy responsible retail distribution prescription veterinarian medicine selfcare product selfcare medicine also available grocery store grocery store oriolakd business environment strategy business area case corporate governance financial statement 16 business area business area oriolakd year 2016 share business area net sale 2016 customer target consumer expert advice health expert service comprehensive customer loyalty programme 1 wellbeing well extensive highquality selection product 483 consumer attractive product range consistent service experience local pharmacy online pharmacy online service service unique service offering pharmacy 2 covering pharmaceutical distribution wide range value adding service 495 pharma company veterinarian tailored customerspecific service coherent service offering superior customer experience clinical research consumer service grocery store healthcare many growing public private improved patient safety business opportunity healthcare 3 market hospital pharmaceutical care dose dispensing home distribution 22 healthcare dentist efficient effective practice optimum use healthcare staff veterinarian time saving cost pharmaceutical oriolakd business environment strategy business area case corporate governance financial statement 17 business area consumer oriolakd year 2016 oriolakd focus need consumer health wellbeing related product service offer expert advice health wellbeing well extensive highquality selection product pharmacy online case excellent service rural sweden nationwide pharmacy chain digital business important part pharmacy sweden kronans apotek 323 pharmacy strength business importance grow 2010 swedish pharmacy skilled personnel indepth knowledge kronans apoteks webshop wwwkronansapotekse market deregulated opened consumer need goal high customer cover kronans apoteks full product assortment traded private actor 32 satisfaction every day good otc prescription medicine always different pharmacy actor sweden want differentiate combining modern want make service easy comfortable kronans apotek one retail customer experience expert advice also customer new mobile application prescrip digital channel extensive assortment tion medicine customer launched autumn 2016 three biggest chain seven year cover high quality beauty wellbeing product finnish healthcare professional later impact market deregula top full pharmacy assortment comple oriolashopfi online shop offer wide assortment tion rural pharmacy seems ment service offering redefined loyalty health beauty product latvia online pharmacy mainly positive program offer variety benefit internetaptiekalvs product assortment consists otc read customer traded good consumer order product delivered directly home chosen delivery address consumer also select pick product ordered online two internetaptieka pharmacy riga owned oriolakd oriolakd business environment strategy business area case corporate governance financial statement 18 business area service oriolakd year 2016 oriolakd reliable supply chain service pharmacy chain wellknown partner sweden offer competitive sourcing supply healthcare actor sweden chain otc pharmaceutical traded good prod ucts pharmacy chain cooperation enables large finland baltic purchasing volume competitive price pharmacy country chain renewed service portfolio widest best expert service oriolakd acquired farenta sector addition pharmaceutical distribu whole medicine lifecycle grows service offering tion cover wide number service make provide unique service portfolio healthcare september 2016 oriolakd customer life easier clinical research sector company partner customer acquired 709 per cent farenta consumer service need succeed market clinical trial finnish company offering service provide service healthcare actor consumer service portfolio service pharmaceutical company farenta want succeed nordic baltic whole lifecycle medicine authority relation country know market producer clinical trial market access pharmaceutical logistics finnish company specializing consumer help customer serve sale marketing service pharmaceutical pharmaceutical service customer better u customer company well expert service pharmacy established 2003 offering grow business increase profitability reach professional service pharmaceu goal marketing healthcare wellbeing product tical company staffing service logistics network cover operating provide wide range traded good sale pharmacy farenta serf country sweden finland estonia lithuania marketing service pharmacy finland 100 pharmaceutical company latvia high quality efficient supply chain baltic country product portfolio includes among 300 finnish pharmacy basis operation ensure others vitamin dietary supplement pharmaceutical product delivered safely warehouse cosmetic skincare product test sport drink read pharmacy hospital veterinary wound care product product selection includes deliver product within 24 hour leading healthcare wellbeing product brand time order placed remote area exclusive brand avène gefilus lysi oriolas big city around year brand pharmacare also product selection grocery trade oriolakd business environment strategy business area case corporate governance financial statement 19 business area healthcare oriolakd year 2016 many growing goal build healthcare business based market customer need providing new 200000 dose dispensing customer sweden still growth potential swedish market business opportunity service healthcare organization like clinic finland far 40000 customer healthcare market hospital svensk do sweden pharmaservice using automated dose dispensing service automated dose dispensing improves patient hospital pharmaceutical finland oriolakds subsidiary specialized life quality patient always trust care dose dispensing dose dispensing service svensk do provides dose dispensed medicine 25000 patient get right medication process simple safe also benefit home distribution via extradition location nursing home society less waste price remain pharmaceutical region skåne direct swedish prison probation service sweden lower oriolakds webshop serf healthcare organ pharmaservice provides supporting service izations veterinary clinic dental clinic automated dose dispensing medicine primary care unit sweden customer 300 contract pharmacy finland serving approx able access unique account easily imately 20000 pharmacy customer order pharmaceutical medical device automated dose dispensing service safe traded good directly clinic pick save money sweden hospital becoming kronans apotek pharmacy sweden increasingly interested service case pharmaservice leading provider automated dose dispensing supporting service finland core pharmaservices business anja auto mated dose dispensing service pharmacy anja pharmacy provide customer twoweek supply tablet capsule taken regularly packed singledose pouch risk medication error read extremely low oriolakd business environment strategy business area case corporate governance financial statement 20 information investor oriolakd year 2016 oriolakd corporation class b share quoted main list nasdaq helsinki ticker symbol class share okdav class b share okdbv company total 181486213 share 55484648 class share 126001565 class b share 31 december 2016 earnings per share share price development 1131122016 eur 024 eur 450 oriolakd b share 31 december 2016 2015 025 eur 425 431 eur dividend 400 014 eurshare 375 350 proposal board director 2015 013 oriolakd bosake omx helsinki cap pi rebased oriolakd business environment strategy business area case corporate governance financial statement 21 oriolakd oriolakd year 2016 investment profit period operate growing healthcare market actively develop service eur 428 million 2015 eur 445 million healthcare sector need solid financial position major shareholder 31 december 2016 total total share vote 1 mariatorp oy 922 914 2 wipunen varainhallinta oy 488 471 dividend earnings 3 ilmarinen mutual pension insurance company 419 616 per share eur 4 varma mutual pension insurance company 418 726 035 eur 029 251 185 030 5 mandatum life insurance company limited 025 024 025 6 mutual insurance company pensionfennia 154 070 020 015 7 fondita nordic micro cap placeringsfond 123 018 015 011 014 010 013 8 medical investment trust oy 114 257 009 005 9 land water technology foundation 113 330 0 0 000 2012 2013 2014 2015 2016 10 social insurance institution 110 016 proposal board director oriolakd business environment strategy business area case corporate governance financial statement 22 responsibility responsibly oriolakd year 2016 manufacturer consumer safe reliable ensuring patient medicine safety important issue u professional service high carry example medicine pharmacy reusable plastic box optimize pharmaceutical distribution quality pharmaceutical advisory phar transport route minimize emission take responsible mission macies important element responsible operation follow strict pharmaceutical consideration energy efficiency new real estate project take care separation handle pharmaceutical sector quality safety procedure phase destruction pharmaceutical waste safe distribution chain distribution chain location oriolakd also many quality management system way sweden consumer bring pharmaceutical waste back collection point producer consumer use kronans apotek pharmacy around year significant environmental impact operation caused pharmaceutical talented personnel important success factor continuous competence develop circumstance transport real estate electricity heating ment good management essential u professional pharmacy staff consumption packaging waste aim minimize impact many different way want employee safe working environment working efficient nice help consumer use medicine responsibly correct way oriolakd business environment strategy business area case corporate governance financial statement 23 responsibility oriolas role oriolakd year 2016 value chain input business model output impact financial ensure pharmaceutical service economical 340 capital health product service pharmaceutical advice value stakeholder employed available close customer dispensing supplier value good sold handled safely efficiently customer employee wage salary human sourcing staffing creditor intrest 2820 employee provide advice safe medicine usage service pharmacy public sector tax whereof 1500 specialist service shareholder dividend pharmacist pharma company manufactured warehousing social 6 distribution center distribution service 325 pharmacy consumer availability safe dispensing medicine 2 dose dispensing unit emission efficiency public private socialrelationships energy consumption healthcare regulator service transportation direct indirect employment medical consumer waste agency emission pharmaceutical industry district heating mwh association healthcare electricity mwh patient organization customer transportation carbon dioxide consumer emission co2 natural sweden finland estonia latvia lithuania waste ton fuel electricity water oriolakd business environment strategy business area case corporate governance financial statement 24 oriolakd year 2016 case new application kronans apotek kronans apotek developed new application support swedish customer prescription app downloadable via appstore google play aim make easier customer keep track recipe thereby also improve medicine usage say anna skarph pharmacist responsible business development kronans apotek logistics shift read gear oriola major new development project completed oriolas quality team develops common oriolas logistics centre international practice espoo 2016 logistics oriolas quality function incorporated one team beginning 2016 development continue change prompted oriolakds new operating model divided lean model company business operation three international business area new read operating model also faded national boundary support function brought people working matter closer together read oriolakd business environment strategy business area case corporate governance financial statement 25 oriolakd acquired pharmaservice oriolakd year 2016 oriolakd acquired pharmaservice oy finnish company offering dose dispensing supporting service association finnish pharmacy orion corporation july 2016 pharmaservice provides supporting service automated dose dispensing medicine anja pharmacy finland serving approximately 20000 pharmacy customer 2015 net sale pharmaservice approximately 14 meur market leader dose dispensing service finland read oriola road show reached oriola shire strengthen 1000 pharmaceutical cooperation professional shire oriola strengthened cooperation 1000 finland sweden 2016 oriola pharmaceutical professional shire sweden ab signed longterm cooperation attended oriola road agreement cooperation agreed show november 2016 extended finland well oriola offer shire road show received good pharmaceutical storage distribution service feedback guest broad range tailored service partner read read oriolakd business environment strategy business area case corporate governance financial statement 26 member board director 20162017 oriolakd year 2016 mr anssi vanjoki chairman b 1956 m eva nilsson bågenholm b 1960 m anja korhonen b 1953 m mariette kristenson b 1977 msc economics physician msc economics msc economics independent member board since vice chairman chairman audit committee independent member board since 2015 chairman compensation independent member board since 2016 committee 2014 share oriolakd corporation 31 dec share oriolakd corporation 31 dec independent member board since 2016 0 class share 9160 class b share share oriolakd corporation 31 dec 2016 0 class share 2202 class b share 2015 2016 0 class share 11754 class b share primary career primary career share oriolakd corporation 31 dec 2012 lappeenranta university primary career 2012 reitan convenience norway ceo 2016 0 class share 5130 class b share technology professor 19962011 nokia oyj senior vice president 20072012 reitan servicehandel sweden 032011 nokia corporation executive vice corporate controller vice president ab marketing director pressbyrån primary career president general manager business controller mobile phone senior 20032007 reitan servicehandel sweden 2015 humana ab quality director 19982011 nokia group executive board vice president business controller nokia ab regional manager pressbyrån 20112014 swedish ministry health member mobile phone 7eleven social affair national coordinator 19831996 hewlettpackard nordic key position trust elderly care key position trust controller finance admin manager member board basware 20022011 sahlgrenska university hospital member board sportamore ab finland european planning reporting corporation atacama lab oy sonova specialist physician internal medicine confederation norwegian manager various manager position holding ag enterprise nho næringslivets key position trust within finance accounting well chairman board amer sport hovedorganisasjon member board foundation development program corporation korulab oy omegawave oy danviks hospital aqsens oy sstatzz oy key position trust member board outotec oyj oriolakd business environment strategy business area case corporate governance financial statement 27 oriolakd year 2016 mr kuisma niemelä b 1958 m lena ridström b 1965 mr matti rihko b 1962 mr staffan simberg b 1949 msc msc economics msc economics msc psychology mba independent member board since independent member board since independent member board since independent member board since 2014 2016 2014 2015 share oriolakd corporation 31 dec share oriolakd corporation 31 dec share oriolakd corporation 31 dec share oriolakd corporation 31 2016 0 class share 9491 class b share 2016 0 class share 2202 class b share 2016 0 class share 10970 class b share dec 2016 0 class share 2202 class b share 152378 class b share primary career primary career primary career nezinvest ab 20102013 sok suomen osuuskauppojen 2013 primelog software ab primelog 20062017 raisio plc ceo keskuskunta ceo chairman holding ab ceo 20042006 altadis sa director zone primary career board 20092013 unitedlog group ab ceo europe 2011 metso group industrial advisor different leadership position within 20072009 unitedlog ab general manager 19992004 altadis finland oy general 2009 2012 cargotec oyj industrial advisor sgroup 30 year software solution manager 20082009 metso panelboard chairman 20032007 axido consulting ab ceo 20072013landis gyr ag member key position trust key position trust founder advisory board member board joutsen finland member board suomen 20012003 ifs sverige ab sale director 20052007 enermet group managing oy alko oy terveystalo oy turku science park oy director chairman board pul nutrition oy key position trust turku chamber commerce 19921994 siarbossard associated partner fresto group oy member board primelog software chairman board turku university 19781991 leading position nokia ab handelsbanken kungsholmen branch office key position trust member advisory board urvalet member board bittium ab corporation chairman board endomines ab publ oriolakd business environment strategy business area case corporate governance financial statement 28 group management team 2016 oriolakd year 2016 member group management team nominated board director group management team convenes regularly address matter concerning entire group group management team decisionmaking body assist president ceo implementation group strategy operational management eero hautaniemi b 1965 sari aitokallio b 1960 thomas gawell b 1963 facilitates groupwide sc econ master law msc econ distribution information president ceo cfo vice president healthcare business concerning entire group managing director oriola ab mr eero hautaniemi president m sari aitokallio appointed chief ceo oriolakd corporation since financial officer cfo oriolakd mr thomas gawell appointed vice change group establishment 2006 mr hautaniemi corporation 16 july 2015 president oriolakds healthcare management team 2016 served president ge healthcare m aitokallio appointed interim cfo business 1 january 2016 mr gawell mr lars birkeland vice president finland oy 20042005 oriolakd corporation member served vice president oriolakds oriolakds consumer business area 12 general manager vice president oriolakd group management team pharmaceutical wholesale business april 2016 mr stig tornell appointed oximetry supply accessory 9 april 2015 m aitokallio hold strong sweden managing director oriola vice president oriolakds consumer business area ge healthcare experience financial management ab 20092015 gawell held business area member oriolakds 20032004 mr hautaniemi position finnish listed company position financial manager oriola group management team 12 april held different position financial ab since 2001 joining oriola ab 2016 business management instrumentarium previously m aitokallio worked gawell held several financial management corporation finland united metso automation division svp finance position 10 year state administration since 2007 earlier expe rience includes several position valmet mr hautaniemi member board metso group finland director lassila tikanoja corporation abroad furthermore m aitokallio worked also member board finnish sponda group 20022006 cfo commerce regional director emea region ifpws international federation pharmaceutical wholesaler board member girp management board girp treasurer girp european association pharmaceutical fullline wholesaler oriolakd business environment strategy business area case corporate governance financial statement 29 oriolakd year 2016 jukka mäkelä b 1963 teija silver b 1964 stig tornell b 1967 kimmo virtanen b 1968 sc msc econ bsc econ sc econ vice president development vice president human resource vice president consumer business executive vice president service business information management managing director kronans apotek managing director oriola oy mr jukka mäkelä appointed vice m teija silver appointed vice deputy ceo oriolakd corporation president development oriolakd president human resource oriolakd mr stig tornell appointed vice corporation april 2013 joining corporation october 2006 joined president oriolakds consumer mr kimmo virtanen appointed oriolakd mr mäkelä worked aedi oy oriolakd ge healthcare finland business member oriolakds group executive vice president oriolakds partner ceo mr mäkelä held position director management team april 12 2016 service business january 1 2016 worked accenture 19902011 human resource m silver mr tornell long experience mr virtanen served executive vice consultant business unit executive served nokia network director retail business different position within president oriolakds pharmaceutical director partner responsible retail manager human resource marketing purchase sale reitan wholesale business finland sweden wholesale manufacturing industry servicehandel sweden ab shell ica baltic country 20122015 group since 2009 mr tornell worked cfo oriolakd corporation pharmacy market first medstop 20062012 previously mr virtanen served previously assortment marketing cfo componenta corporation director kronans apotek since 2013 20032006 cfo danisco sweetener uk finland 19992003 held several management position cultor corporation 19951999 oriolakd business environment strategy business area case corporate governance financial statement 30 oriolakd year 2016 phase life oriolakd business environment strategy business area case corporate governance financial statement 31 report board director financial statement 2016 oriolakd year 2016 report board director 32 48 trade payable liability 55 8 note 72 shareholding 37 481 trade payable current liability 55 81 income tax 72 482 noncurrent liability 55 811 income tax 72 share related key figure 38 49 operating profit 55 812 tax related comprehensive income 72 largest shareholding 39 5 tangible intangible asset leasing 813 tax rate reconciliation 72 financial indicator 40 arrangement depreciation amortisation 55 82 deferred tax asset liability 72 51 property plant equipment 55 821 deferred tax asset liability 73 calculation financial ratio 42 84 event balance sheet date 74 511 property plant equipment 56 consolidated statement 52 finance lease 57 9 parent company financial statement 74 comprehensive income ifrs 43 521 asset leased finance lease parent company income statement fa 74 consolidated statement financial position ifrs 44 agreement 57 522 maturity finance lease liability 57 parent company balance sheet fa 75 consolidated statement cash flow ifrs 45 53 intangible asset 57 parent company cash flow statement fa 76 consolidated statement change equity ifrs 46 531 intangible asset 58 note parent company note consolidated financial statement 47 532 allocation impairment testing goodwill 59 financial statement fa 77 1 basic information company 47 6 capital structure financing cost 60 10 proposal profit distribution signature 2 basis presentation 47 61 financing cost 60 board director report 3 use estimate 47 611 financial income expense 60 financial statement auditor note 82 311 use estimate 47 62 financial asset liability 60 621 financial asset liability 61 11 auditor report translation finnish 4 operating result 47 622 fair value hierarchy 62 original 83 41 segment reporting 47 623 reconciliation financial liability 12 corporate governance statement 2016 88 411 invoicing 48 recognised fair value profit loss remuneration statement 94 412 adjusted ebitda adjusted operating profit 48 according level 3 62 413 adjusting item 48 624 cash cash equivalent 62 information shareholder 97 414 reporting segment 48 625 borrowing 62 415 geographical information 49 626 contingent liability 63 42 operating income 49 63 financial risk management 63 reading instruction oriolakd financial statement 421 net sale currency 49 631 maturity distribution financial liability 422 operating income 49 derivative liability 64 423 trade receivables 50 oriolakd aim facilitate reading 632 derivative 65 financial statement clarify overall 43 operating expense 50 64 equity share authorisation 65 431 cost good sold 50 picture given statement note financial 641 share capital 67 statement combined according 432 inventory 51 65 earnings per share dividend equity 433 operating expense 51 topic applicable accounting principle distribution 68 described together note 44 employee benefit 51 651 earnings per share 68 441 employee benefit 51 442 postemployment benefit 52 7 consolidation 69 71 group company relatedparty transaction 69 accounting principle 443 sharebased payment 53 444 management benefit 54 711 group company 69 accounting principle marked grey background 445 salary benefit 72 business combination 70 member board director 54 721 business combination 70 73 application new amended ifrs standard use estimate 45 leasing contract 54 451 group lessee 54 ifric interpretation 70 explanation use estimate attached 46 provision 54 revenue stream 71 note marked grey background italic 47 audit fee 55 471 audit fee 55 oriolakd business environment strategy business area case corporate governance financial statement 32 financial statement report board director oriolakd year 2016 operating environment healthcare segment increased cost result good result increased competition profitability oriolakds operating environment affected number consumer business previous year level burdened higher establishment cost sweden new megatrends pharmaceutical healthcare business depreciation swedish krona application prescription customer launched pharmaceutical market polarization high value corresponding period impacted euro denominated share online sale sweden less 2 per cent specialty pharmaceutical price sensitive generic create operating profit eur 06 million development continues along development demand highly customized logistically efficient oriolakds net financial expense eur 47 65 million pharmacy network storage distribution solution spend healthcare profit period eur 428 445 million income tax wellbeing increasing country oriolakd operates januarydecember 113 115 corresponds service business area change pharmaceutical regulatory environment along effective tax rate 209 206 per cent earnings per share service business area offer tailored service pharma change pricing reimbursement continue eur 024 025 ceutical company pharmacy sweden finland impact market oriolakd operates baltic country addition oriolakd service offer swedish pharmaceutical retail market consumer business area sale marketing service large assortment traded competition intensifying happening consumer business area focus need good finland baltic country increase physical store well online sale consumer health wellbeing related product pharmaceutical market wholesale price sweden assortment traded good pharmacy expanding service business consists retail business sweden grew 48 79 per cent swedish krona source ims cater change customer demand pharmaceutical finland latvia whereof 90 per cent net sale health januarydecember 2016 oriolakds share logistics business seeing increasing number order originates swedish retail business swedish pharmaceutical wholesale market approxi line time number stock keeping unit pharmaceutical retail market sweden grew 55 mately 40 39 per cent oriolakd estimate also increasing creates need agile efficient 67 per cent swedish krona januarydecember 2016 finnish pharmaceutical market wholesale price logistics solution source apoteksförening parallel import share grew 37 33 per cent januarydecember 2016 source healthcare sector social healthcare reform swedish pharmaceutical market 12 10 per cent source ims express oriolakds share finnish pharmaceutical finland expected impact also pharmaceutical ims health number pharmacy sweden increased wholesale market 46 46 per cent source aty distribution dispensing although still unclear 36 pharmacy januarydecember 2016 end invoicing service business area increased actual effect benefit safety december 1394 1358 pharmacy sweden previous year 47 73 per cent eur 29346 28020 cost efficiency dose dispensing contributed oriolakds market share pharmaceutical retail million constant currency basis invoicing increased increase number dose dispensing patient market sweden januarydecember 2016 181 185 55 per cent net sale decreased 06 increased 06 per finland sweden per cent source apoteksförening oriolakds relative share cent eur 11758 11834 million constant currency otc traded good net sale 27 26 per basis net sale increased 02 per cent adjusted operating oriolakds net sale result 2016 cent swedish consumer business end profit increased 43 93 per cent eur 347 332 million oriolakds net sale increased 10 09 per cent reporting period oriolakd total 325 311 pharmacy constant currency basis adjusted operating profit eur 16421 16263 million adjusted operating profit 323 309 sweden 2 2 latvia increased 48 per cent increased 04 30 per cent eur 611 608 million net increase januarydecember 14 pharmacy oriolakd acquired 709 per cent farenta oy 1 adjusting item eur 22 18 million operating net sale consumer business area increased september 2016 additionally oriolakd agreed right profit eur 588 626 million januarydecember net 20 14 per cent eur 7925 7771 million constant acquire remaining share farenta company sale comparable exchange rate eursek eur 16571 currency basis net sale increased 32 per cent adjusted consolidated service business area million operating profit decreased 11 increased 09 per cent wholly owned farenta offer professional service pharma invoicing increased 48 66 per cent line market eur 334 337 million constant currency basis adjusted ceutical company staffing service pharmacy growth main market growth service operating profit increased 01 per cent new distribution agreement made meda business exceeded market growth consumer consumer business area sale growth weaker sweden sale meda wholesale price approx business growth weaker profitability market growth decline market share mainly imately sek 11 billion sweden 2015 distribution supported service segment establishment prescription medicine also otc traded agreement abbvie sweden discontinued oriolakd business environment strategy business area case corporate governance financial statement 33 financial statement sale abbvie wholesale price approximately sek loan extending maturity loan portfolio personnel 13 billion sweden 2015 31 december 2016 longterm interest bearingliabilities end 2016 oriolakd payroll 2821 2353 eur 846 669 million shortterm interestbearing employee 59 67 per cent worked consumer oriolakd year 2016 healthcare business area liability eur 485 617 million shortterm liability business area 35 31 per cent service business area healthcare business area offer service hospital mainly consists syndicated loan eur 105 109 million 4 per cent healthcare business area group healthcare centre healthcare sector operator commercial paper issue eur 150 130 million administration employed 2 2 percent total number oriolakds healthcare business area started operation advance payment finnish pharmacy eur 215 239 employee personnel number consist member staff 1 january 2016 acquisition dose dispensing million interestbearing net debt eur 723 66 million active employment company svensk do ab completed 8 february 2016 gearing 352 34 per cent competent contented staff success factor acquisition pharmaservice oy completed nonrecourse trade receivables sale programme oriolakd competence development good leadership 18 july 2016 end 2016 oriolakd served approxi continued sweden januarydecember 2016 therefore particularly important 2016 focused mately 47 000 person dose dispensing sweden end december 2016 total eur 1185 1146 million developing manager leadership change finland fourth quarter new agreement trade receivables sold including sold trade management skill drive ongoing development made county council norrland sweden service receivables adjusted gearing 930 623 per cent program regularly measure employee engagement start february 2017 cover approximately 19000 average interest rate interest bearing liability 126 develop work environment leadership way person 150 per cent working oriolakd care total wellbeing net sale healthcare business area eur 362 committed longterm revolving credit facility eur employee group finnish entity wellbeing million adjusted operating loss eur 10 million 1000 million eur 152 million shortterm credit limit survey piloted spring 2016 support amortization related acquisition svensk do unused end december occupational health care individual development action pharmaservice affected healthcare business area operating end 2016 oriolakds equity ratio 227 211 initiated maintain improve ability work profit eur 17 million additionally goodwill impairment percent return capital employed 178 199 per cent wellbeing personal level eur 64 million recorded due annulled sjuklövern dose longterm target 20 per cent adjusted gearing oriolakds employee age distribution balanced dispensing contract hand group recorded 930 per cent fell short target 3060 per cent due approximately 27 per cent employee 30 eur 63 million income reason contingent acquisition svensk do farenta pharmaservice year old 45 per cent 3050 year 28 per purchase price liability dissolved 2016 strategic investment efficiency cent 50 year old approximately 80 per cent healthcare business area oriolakd specializes logistic operation sweden oriolakds employee female also 77 per cent pharmaceutical dose dispensing hospital pharmacy service managerial position occupied woman due service private health care actor veterinarian investment fact pharmacist professional consumer business cost developing capability negatively gross investment januarydecember 2016 totalled eur area predominantly female service healthcare impacted 2016 profitability segment 888 204 million consisted investment related business area administrative position split acquisition svensk do pharmaservice farenta even balance sheet cash flow financing group opening new pharmacy information system oriolakds total asset 31 december 2016 eur 9254 improvement logistics efficiency depreciation amorti environmental social governance development 9469 million equity attributable equity holder sation impairment amounted eur 322 226 million oriolakd eur 2052 1946 million cash cash equivalent totalled investment plan approximately eur 20 million 2016 oriolakd started prepare esg reporting 2017 eur 608 1219 million net cash flow operation group operative platform automation annual reporting januarydecember 2016 eur 401 856 million distribution centre finland approved 2015 pharmaceutical wholesaler pharmacy operator change working capital accounted eur 437 112 investment realized 20152018 2016 oriolakd responsible role pharmaceutical million net cash flow investing activity eur 807 decision approximately eur 22 million investment supply chain oriolakd handle delivers pharmaceutical 199 million net cash flow financing activity eur expansion automation distribution centre manufacturer product safely efficiently time 204 352 million warehouse 20162018 sweden made based provides appropriate pharmaceutical advice high quality end december 2016 interestbearing debt decision total annual capital expenditure group pharmacy eur 1331 1286 million november 2016 threeyear eur 20162018 excluding acquisition estimated patient pharmaceutical safety 30 million term loan taken refinancing short term approximately eur 35 million important requirement governing oriolakds operation oriolakd business environment strategy business area case corporate governance financial statement 34 financial statement pharmaceutical manufacturer product must delivered remuneration committee member eva nilsson corporategovernance corporate governance statement patient safely efficiently time regardless bågenholm chairman mariette kristenson lena ridström remuneration statement 2016 circumstance professional customer service pharmaceutical matti rihko prepared accordance corporate governance code oriolakd year 2016 advice comprehensive product range high quality board director assessed independence 2015 key factor ensuring success oriolakd pharmacy member board determined member competent contented staff constitutes key success board independent company major authorization factor oriolakd continuous development competence shareholder agm authorised board director decide good personnel management therefore particularly pricewaterhousecoopers oy nominated share issue payment one issue important oriolakd wish create environment authorized public accountant ylva eriksson principal authorisation comprises right issue new share personnel working towards common target auditor reelected auditor company assign treasury share held company authori performed safely efficiently board director oriolakd appointed 23 sation cover maximum 5650000 class share work environment concentrate find september 2016 company nomination committee 12500000 class b share representing approximately 1000 implement energy efficient solution warehousing pekka pajamo chairman peter immonen timo leino mikko per cent share company includes right distribution well reduce recycle waste mursula ylppö derogate shareholder preemptive subscription handling pharmaceutical waste part oriolakds reporting period 31 january 2017 right pursuant authorisation share held service nomination committee oriolakd presented board company treasury share may also sold trading director recommendation proposal 2017 regulated market organised nasdaq helsinki ltd resolution annual general meeting annual general meeting concerning composition authorisation effect period eighteen month annual general meeting agm held 14 march board director follows decision agm 2016 adopted financial statement discharged number member board director would agm authorised board director decide member board director president ceo seven present member board director share issue payment one issue liability financial year ending 31 december 2015 anja korhonen mariette kristenson kuisma niemelä eva authorisation comprises right issue new class b share agm resolved dividend eur 013 per share shall nilsson bågenholm lena ridström staffan simberg assign class b treasury share held company paid basis balance sheet adopted anssi vanjoki would reelected anssi vanjoki would authorisation cover combined maximum 18000000 financial year ending 31 december 2015 payment date reelected chairman board director class b share company representing approximately dividend 5 april 2016 current member board director matti rihko 992 per cent share company includes agm resolved amend following article informed nomination committee available right derogate shareholder preemptive company article association accordance reelection board director 2017 annual subscription right pursuant authorisation class b proposal board director age limit board general meeting share held company treasury share may also member elect removed 5 possibility oriolakds group management team consists seven sold regulated market organised nasdaq helsinki ltd deliver notice annual general meeting member eero hautaniemi president ceo sari aitokallio authorisation effect period eighteen month publishing notice company website added cfo thomas gawell vice president healthcare business decision agm 12 area jukka mäkelä vice president development stig tornell authorisation revoke previous share issue decision annual general meeting 2016 vice president consumer business area teija silver vice authorisation given board director apart available company website wwworiolakdcom president hr kimmo virtanen executive vice president authorisation given board director annual service business area general meeting held 20 march 2013 pursuant corporate governance lars birkeland vice president consumer business board director may decide upon directed share issue annual general meeting confirmed board area member group management team left without payment concerning director composed eight member anssi vanjoki company april 12 2016 stig tornell appointed vice 1715000 class b share order execute sharebased chairman eva nilsson bågenholm vice chairman mariette president consumer business area member group incentive plan oriolakd group executive kristenson anja korhonen kuisma niemelä lena ridström management team april 12 2016 share saving plan oriolakd group key personnel matti rihko staffan simberg corporate governance statement agm also authorised board director decide board audit committee member anja korhonen remuneration statement 2016 viewed repurchasing company class b share chairman kuisma niemelä staffan simberg board company website httpwwworiolakdcom authorisation entitles board director decide oriolakd business environment strategy business area case corporate governance financial statement 35 financial statement repurchase 18000000 company based oriolakd group earnings per share eps acquisition approximately 71 per cent farenta oy 1 class b share representing approximately 992 per cent calculated adjusted earnings excluding tax september 2016 share company authorisation may used reward paid 2018 basis performance oriolakd year 2016 way total one tenth share period 2015 correspond value 247541 oriolakd risk internal control company may time time possession corporation class b share including proportion oriolakd specified company risk management company subsidiary share may repurchased paid cash model principle organization process risk also proportion share owned 4 december 2015 board director oriolakd management policy group risk management seek shareholder share may repurchased develop corporation established sharebased incentive plan identify measure manage risk may impact company capital structure execute corporate transac directed group key personnel plan cover three oriolakds operation achievement set goal tions business arrangement finance investment performance period 20162018 three vesting period additionally group code conduct policy used part company incentive scheme 20172019 prerequisite participation plan treasury policy covering compliance financial risk otherwise relinquished held company cancelled key person enrolled share saving plan okshares internal control risk management system related authorisation repurchase share force make monthly saving fixed gross oriolakds financial reporting aim ensure reliability period eighteen month decision monthly salary company financial statement financial reporting agm authorisation revoke authorisation potential reward performance period 2016 well company compliance legislation given board director agm 30 march 2015 based group eps reward paid basis generally approved accounting principle respect repurchase company class b share performance period 2016 correspond value oriolakd operates regulated pharmaceutical distri approximately 200000 oriolakd corporation class b share bution retail market main megatrends impacting oriolakd corporation share including proportion paid cash similarly oriolakds business environment increased spending oriolakd corporation market capitalisation 31 december potential reward performance period 2017 health wellbeing growth specialty pharmaceutical 2016 eur 7789 7796 million based group eps effort control growth cost public review period traded volume oriolakd total 39 key employee participated oriolakd healthcare digitalization retail trade corporation share excluding treasury share corresponded corporation key personnel share saving plan service 134 219 per cent total number share saving period 1 october 201430 september 2015 total oriolakd identified following principal strategic end december 2016 company total 31 212 matching share including proportion paid cash operational risk adverse impact 181486213 181486213 share 55484648 transferred eligible participant november 2016 result change pharmaceutical market regulation 55484648 class share 126001565 126001565 approximately 50 key employee participated pricing public reimbursement well increased class b share company 96822 96822 treasury saving period 1 october 201531 december 2016 total competition growing number pharmacy share class b share account 005 57 key employee enrolled oriolakd corporation company ecommerce decreasing share single 005 per cent company share 001 001 per cent key personnel share saving plan saving period 1 channel distribution public healthcare loss several vote january31 december 2017 accumulated saving key pharmaceutical company agreement article 3 article association shareholder used purchasing oriolakds class b share main financial risk oriolakd involve currency rate may demand conversion class share class b share participant market price return participant liquidity interest rate credit risk change value period 1 january30 december 2016 class receive two free class b matching share every three swedish krona impact oriolakds net sale share converted class b share 1093804 acquired saving share matching share paid partly earnings consolidated statement financial position flagging announcement received 2016 oriolakds class b share partly cash change cash flow forecast cause goodwill writeoff information share shareholding found share shareholding change group structure 2016 nearterm risk uncertainty factor oriolakd completed acquisition swedish dose oriolakds strategic development project involve sharebased incentive plan dispensing company svensk do ab 8 february 2016 operational risk may effect oriolakds 19 december 2012 oriolakd corporation board second quarter oriolakd established new profitability director decided share incentive scheme group subsidiary estonia carry existing brand oriolakd involved number legal action claim senior management year 20132015 scheme pharmaceutical marketing business oriolakd completed proceeding oriolakds policy provide covered six person reward 2015 earning period acquisition pharmaservice oy 18 july 2016 amount related proceeding liability probable oriolakd business environment strategy business area case corporate governance financial statement 36 financial statement amount thereof estimated reasonable certainty board proposes annual general meeting taking account available information date legal dividend eur 014 013 per share paid 2016 action claim proceeding expected oriolakd year 2016 material impact financial position group annual general meeting oriolakd corporation annual general meeting held market outlook 14 march 2017 2 pm helsinki fair centre oriolakds outlook 2017 based external market matter specified article 10 article association forecast agreement pharmaceutical company proposal board director pharmacy management assessment finnish dealt meeting board director pharmaceutical market expected grow 20152020 decide notice annual general meeting average rate 11 per cent swedish pharmaceutical proposal contained later date notice market expected grow average rate 42 per cent per convene available company website year local currency source ims health wwworiolakdcom 16 february 2017 outlook 2017 information heading share shareholder oriolakd undergoing major development phase financial indicator part report board started 2015 estimated completed end director 2018 cost related development project intensified competition swedish retail especially espoo 10 february 2017 online negatively impact 2017 profitability oriolakd estimate adjusted operating profit oriolakd corporation constant currency basis remain 2016 level board director event period oriolakd corporation 50375 ashares converted bshares accordance section 3 article association oriolakd corporation 50375 ashares converted 50375 bshares conversion entered trade register 4 january 2017 conversion 55434273 ashares 126051940 bshares company total number share 181486213 total number vote 1234737400 31 january 2017 nomination committee oriolakd presented board director recommendation proposal 2017 annual general meeting concerning composition board director proposal presented corporate governance profit distribution proposal oriolakds parent company oriolakd corporation whose distributable asset based balance sheet 31 december 2016 eur 3663 3688 million oriolakd corporation profit financial year 2016 eur 211 402 million earnings per share eur 024 025 oriolakd business environment strategy business area case corporate governance financial statement 37 financial statement shareholding share shareholder oriolakd year 2016 shareholder type owner 31 december 2016 shareholder shareholder share share b share total share b share total share b share total individual 10357 21231 27318 965 956 957 460 284 338 corporation partnership 234 558 736 22 25 26 170 103 123 bank insurance company 13 49 51 01 02 02 121 253 212 public entity 5 14 17 00 01 01 143 85 103 association foundation 74 249 296 07 11 10 54 34 40 foreign shareholder 48 114 140 04 05 05 05 25 19 total 10731 22215 28558 1000 1000 1000 953 784 836 nominee registration 46 216 164 jointbookentry account 01 00 01 shareholder number share held 31 december 2016 shareholder shareholder number share share b share total share b share total 1100 1517 2227 3089 141 100 108 1011000 5544 12238 15289 517 551 535 100110000 3272 7109 9077 305 320 318 10001100000 352 562 985 33 25 34 100001 46 79 118 04 04 04 total 10731 22215 28558 1000 1000 1000 nominee registered 5 10 10 share share number share share b share total share b share total 1100 79790 128006 207796 01 01 01 1011000 2357294 5345464 7702758 42 42 42 100110000 9309119 19079438 28388557 168 151 156 10001100000 9123347 12931010 22054357 164 103 122 100001 34549816 88455425 123005241 623 702 678 total 55419366 125939343 181358709 999 1000 999 nominee registered 2543561 27155845 29699406 46 216 164 jointbookentry account 65282 62222 127504 01 00 01 55484648 126001565 181486213 1000 1000 1000 oriolakd business environment strategy business area case corporate governance financial statement 38 financial statement share related key figure 2016 2015 20143 2013 2012 1 oriolakd year 2016 earnings per share eur 024 025 133 004 011 earnings per share continuing operation eur 024 025 028 011 015 equity per share eur 113 107 069 184 205 total dividend eur million 254 2 236 76 dividend per share eur 014 2 013 01 payout ratio 583 2 517 440 dividend yield 329 2 307 22 dividend yield b 325 2 301 22 repayment equity eur 2 004 pe ratio 1798 1690 1176 2364 1537 pe ratio b 1824 1722 1180 2318 1509 share price 31 dec eur 425 424 326 260 227 share price 31 dec b eur 431 432 327 255 223 average share price eur 416 401 237 240 204 average share price b eur 420 406 234 238 195 lowest share price eur 370 293 189 224 177 lowest share price b eur 365 284 198 218 170 highest share price eur 450 452 331 269 244 highest share price b eur 465 460 330 273 225 market capitalisation eur million 7789 7796 5244 3881 3392 trading volume share pc 1893721 3045353 7868093 3215623 5674171 average number share 34 55 157 68 120 b share pc 22488841 35816293 41162592 28601043 29496044 average number b share 179 293 372 275 284 average number share 134 219 305 211 233 number share 31 dec pc 55484648 55484648 50147044 47148710 47148710 b pc 126001565 126001565 110729744 104109118 104109118 total number share 31 dec pc 181486213 181486213 160876788 151257828 151257828 total number share annual average pc 55484648 55204784 50147044 47148710 47148710 total number b share annual average pc 126001565 122441865 110729744 104109118 104109118 total number share annual average3 pc 181486213 177646649 160876788 151257828 151257828 1 comparative figure adjusted retroactively according revised standard ia 19r 2 proposal board director 3 calculated based right issue adjusted number share right issue factor 106359 oriolakd business environment strategy business area case corporate governance financial statement 39 financial statement largest shareholding number oriolakd year 2016 number share held 31 december 2016 share b share total share total share vote total vote vote 1 mariatorp oy 5063948 11670000 16733948 922 112948960 914 1 2 wipunen varainhallinta oy 2600000 6250000 8850000 488 58250000 471 4 3 ilmarinen mutual pension insurance company 3606414 3995536 7601950 419 76123816 616 3 4 varma mutual pension insurance company 4320600 3273000 7593600 418 89685000 726 2 5 mandatum life insurance company limited 960000 3600000 4560000 251 22800000 185 9 6 mutual insurance company pensionfennia 310162 2484289 2794451 154 8687529 070 13 7 fondita nordic micro cap placeringsfond 0 2225000 2225000 123 2225000 018 8 medical investment trust oy 1560000 510540 2070540 114 31710540 257 7 9 land water technology foundation 2041832 0 2041832 113 40836640 330 5 10 social insurance institution 0 1991481 1991481 110 1991481 016 11 tukinvest oy 1983526 0 1983526 109 39670520 321 6 12 ylppö jukka 1496562 286992 1783554 098 30218232 245 8 13 aktia capital fund 0 1747772 1747772 096 1747772 014 14 odin finland 0 1657000 1657000 091 1657000 013 15 kaleva mutual pension insurance company 277942 1200000 1477942 081 6758840 055 15 16 nordea fennnia fund 0 1291825 1291825 071 1291825 010 17 sijoitusrahasto evli finnish small cap 0 1129269 1129269 062 1129269 009 18 state pension fund 0 1000000 1000000 055 1000000 008 19 finnish cultural foundation 390021 601200 991221 055 8401620 068 14 20 nordea pro finland fund 0 967959 967959 053 967959 008 total 24611007 45881863 70492870 3884 538102003 4355 nominee registred 2543561 27155845 29699406 1636 78027065 631 28330080 52963857 81293937 4479 619565457 5014 shareholder total 55484648 126001565 181486213 10000 1235694525 10000 oriolakd business environment strategy business area case corporate governance financial statement 40 financial statement financial indicator oriolakd year 2016 consolidated income statement 2016 2015 20144 2013 20121 net sale eur million 16421 16263 16123 16197 15218 international operation eur million 12697 12406 12240 12368 10993 net sale 773 763 759 764 722 adjusted operating profit eur million 611 608 591 370 291 net sale 37 37 37 23 19 operating profit eur million 588 626 650 293 281 net sale 36 38 40 18 18 financial income expense eur million 47 65 78 84 10 net sale 03 04 05 05 01 profit tax eur million 541 561 571 209 271 net sale 33 34 35 13 18 profit period eur million 428 445 465 171 223 net sale 26 27 29 11 15 consolidated balance sheet eur million 2016 2015 20144 2013 20121 noncurrent asset 4372 3964 3908 5618 4231 goodwill 2868 2565 2509 3790 2767 current asset 4883 5505 4832 9383 8931 inventory 1994 2011 1850 3914 3898 equity attributable parent company shareholder 5 2052 1946 1115 2781 3105 liability total 5 7203 7523 7625 12220 10056 interestbearing liability 1331 1286 1939 3188 948 noninterestbearing liability 5 5872 6237 5686 9032 9109 total asset 9254 9469 8740 15001 13162 group adjusted operating profit 70 eur million 04 14 10 02 60 608 611 50 40 30 20 10 0 2015 consumer service healtcare group 2016 item oriolakd business environment strategy business area case corporate governance financial statement 41 financial statement oriolakd year 2016 key figure 2016 2015 20144 2013 20121 equity ratio 5 227 211 131 192 245 equity per share 5 eur 113 107 069 184 205 return capital employed roce 2 178 199 144 42 59 return equity 2 5 214 291 239 20 54 net interestbearing debt eur million 723 66 1024 1815 67 gearing 5 352 34 918 653 21 net interestbearing debt ebitda continuing operation ratio 08 01 12 37 02 earnings per share continuing operation 4 eur 024 025 028 011 015 earnings per share incl discontinued operation 4 eur 024 025 133 004 011 average number share 3 4 pc 181389391 177501818 160741152 151157494 151247748 average number personnel continuing operation pers 2582 2327 2377 2156 1784 gross capital expenditure incl discontinued operation eur million 888 204 340 1937 226 net sale adjusted operating profit adjusted ebitda 1800 90 100 eur million eur million eur million 1600 80 90 1642 80 1620 1612 1626 1400 70 868 1522 834 813 1200 60 70 60 608 611 1000 50 591 50 559 800 40 40 600 30 425 30 370 400 20 291 20 200 10 10 0 0 0 2012 2013 2014 2015 2016 2012 2013 2014 2015 2016 2012 2013 2014 2015 2016 1 comparative figure adjusted retroactively according revised standard ia 19r 2 comparative figure 20132012 include discontinued operation 3 companyowned treasury share included 4 average number share adjusted right issue 2014 5 2015 statement financial position restated due error relating prior period restatement increased deferred tax liability eur 21 million decreased equity corresponding amount oriolakd business environment strategy business area case corporate governance financial statement 42 financial statement calculation financial ratio oriolakd year 2016 equity total equity ratio 100 total asset advance received operating profit continuing operation return capital employed roce 100 total asset noninterestbearing liability average beginning 100 end year profit period continuing operation return equity roe 100 equity total average beginning end year interestbearing liability cash cash equivalent gearing 100 equity total interestbearing liability cash cash equivalent net interestbearing debtebitda operating profitloss continuing operation depreciation amortization impairment loss profit attributable shareholder parent company earnings per share eps eur average number share period equity attributable shareholder parent company equity per share eur number share end period dividend paid financial period dividend per share eur number share end period dividend per share payout ratio 100 earnings per share dividend per share effective dividend yield 100 closing price last trading day financial period closing price last trading day financial period priceearnings ratio pe earnings per share trading volume eur average price share eur average number share traded financial period market capitalisation eur number share end financial period closing price last trading day financial period oriolakd business environment strategy business area case corporate governance financial statement 43 financial statement consolidated statement comprehensive income ifrs oriolakd year 2016 eur million note 2016 2015 eur million note 2016 2015 net sale 414415 421 16421 16263 item reclassified profit operating income 422 202 149 loss cost good sold 431 12916 12984 actuarial gainslosses defined benefit plan 442 05 56 employee benefit expense 441 1545 1438 income tax relating comprehensive income 812 01 11 operating expense 433 1252 1139 04 44 gross profit 910 851 depreciation amortisation impairment 511 531 322 226 total comprehensive income period 340 528 operating profit 414 588 626 financial income expense 611 47 65 profit attributable profit tax 541 561 parent company shareholder 428 446 income tax 811813 113 115 profit period continuing operation 428 445 total comprehensive income attributable profit period discontinued operation 01 parent company shareholder 340 528 profit period 428 446 earnings per share attributable parent comprehensive income company shareholder item may reclassified subsequently basic earnings per share eur profit loss continuing operation 651 024 025 translation difference recognised comprehensive discontinued operation 651 000 income reporting period 812 91 36 profit period 651 024 025 cash flow hedge 812 08 01 diluted earnings per share eur income tax relating comprehensive income 812 02 00 continuing operation 651 024 025 85 37 discontinued operation 651 000 profit period 651 024 025 oriolakd business environment strategy business area case corporate governance financial statement 44 financial statement consolidated statement financial position ifrs oriolakd year 2016 31 dec 31 dec 31 dec 31 dec eur million note 2016 2015 eur million note 2016 2015 asset equity liability noncurrent asset equity property plant equipment 511 715 727 share capital 362 362 goodwill 531532 2868 2565 hedging reserve 06 12 intangible asset 531 762 632 contingency fund 194 194 noncurrent asset 03 03 invested unrestricted equity 748 748 deferred tax asset 821 24 37 reserve 01 02 noncurrent asset total 4372 3964 translation difference 86 05 retained earnings 838 647 current asset equity attributable parent company inventory 432 1994 2011 shareholder 64 2052 1946 trade receivables 423 1926 1940 receivables 423 354 334 noncurrent liability cash cash equivalent 624 608 1219 deferred tax liability 821 162 158 current asset total 4883 5505 pension obligation 442 106 100 borrowing 625 846 669 asset total 414415 9254 9469 noncurrent liability 482 34 21 noncurrent liability total 414 1148 947 asset current liability trade payable 481 5043 5477 borrowing 625 485 617 1000 eur million 900 current liability 481 527 481 140 150 800 current liability total 414 6054 6575 700 256 600 287 500 equity liability total 9254 9469 400 300 550 noncurrent asset 488 equity liability 200 goodwill 100 0 current asset 2015 2016 1000 eur million 900 195 800 205 700 95 115 600 500 400 658 300 605 equity 200 noncurrent liability 100 0 current liability 2015 2016 oriolakd business environment strategy business area case corporate governance financial statement 45 financial statement consolidated statement cash flow ifrs oriolakd year 2016 eur million note 2016 2015 eur million note 2016 2015 net cash flow operating activity net cash flow investing activity operating profit 588 627 investment property plant equipment adjustment intangible asset 358 113 depreciation amortisation 511531 258 226 proceeds sale property plant impairment 531 64 equipment intangible asset 18 85 change pension asset pension obligation 07 34 business acquisition net cash acquired 467 adjustment 73 27 net cash flow investing activity 807 199 990 913 net cash flow financing activity change working capital proceeds share issue 756 change current receivables increase share issue expense 18 decrease 06 272 repayment hybrid bond 400 change inventory increase decrease 23 188 purchasing share 01 change noninterestbearing current liability repayment shortterm loan 1 269 355 increase decrease 454 572 proceeds longterm loan 300 437 112 repayment longterm loan 288 interest paid hybrid bond 45 interest paid financial expense 61 72 dividend paid return equity 236 dividend received net cash flow financing activity 204 352 interest received financial income 03 03 income tax paid 94 100 net change cash cash equivalent 610 306 net cash flow operating activity 401 856 cash cash equivalent beginning period 1219 915 translation difference 01 01 net change cash cash equivalent 610 306 cash cash equivalent end period 624 608 1219 1 includes cash flow commercial paper oriolakd business environment strategy business area case corporate governance financial statement 46 financial statement consolidated statement change equity ifrs oriolakd year 2016 equity attributable parent company shareholder share translation retained hybrid eur million note capital fund difference earnings bond equity total equity 1 january 2015 362 193 31 195 396 1115 comprehensive income period net profit period 446 446 comprehensive income cash flow hedge 01 01 actuarial gain loss 442 56 56 income tax relating comprehensive income 812 00 11 12 translation difference 36 36 comprehensive income period total 01 36 491 528 transaction owner share issue 737 737 hybrid bond interest 26 26 redemption hybrid bond 64 13 396 410 sharebased incentive 03 03 distributed treasury share 01 01 purchase share 00 00 transaction owner total 737 38 396 303 equity 31 december 2015 362 931 05 647 1946 comprehensive income period net profit period 428 428 comprehensive income cash flow hedge 08 08 actuarial gain loss 442 05 05 income tax relating comprehensive income 812 02 01 00 translation difference 91 91 comprehensive income period total 06 91 425 340 transaction owner dividend distribution 236 236 sharebased incentive 03 03 distributed treasury share 01 01 transaction owner total 234 234 equity 31 december 2016 362 937 86 838 2052 oriolakd business environment strategy business area case corporate governance financial statement 47 financial statement note consolidated financial statement oriolakd year 2016 1 basic information company 3 use estimate oriolakd corporation finnish public limited company domiciled espoo finland oriolakd subsidiary together form consolidated oriolakd group use estimate preparation consolidated financial statement accordance ifrs requires application judgement management making estimate assumption estimate consolidated financial statement approved publication board director assumption impact asset liability reported end reporting period oriolakd corporation 10 february 2017 accordance finland limited liability presentation contingent asset liability note consolidated financial company act shareholder right approve reject financial statement statement well income expense reported financial year estimate general meeting held publication general meeting may also decide based management best knowledge fact actual result may differ make amendment financial statement company business id 19992150 estimate assumption used accounting estimate used determining amount copy consolidated financial statement oriolakd group available item reported consolidated financial statement possible impairment goodwill head office oriolakd corporation following address orionintie 5 fi02200 espoo asset determination pension asset pension obligation related defined benefit finland investorrelationsoriolacom pension plan economic life tangible intangible asset provision tax application accounting principle also requires judgement 311 use estimate 2 basis presentation item uncertainty note basis presentation financial statement prepared accordance international financial reporting standard including adherence ia ifrs standard sic ifric defined benefit discount factor 442 interpretation valid 31 december 2016 international financial reporting standard refer impairment testing discount factor estimate 532 standard interpretation approved application eu finnish deferred tax recognition estimate 821 accounting act provision issued pursuant according procedure provided eu regulation ec 16062002 4 operating result consolidated financial statement presented 12month period 1 january 31 december 2016 financial statement presented eur million prepared 41 segment reporting historical cost convention except financial asset recognised fair value profit loss financial asset availableforsale derivative sharebased payment group segment reporting operating segment reported internal reporting provided applied following new amended standard interpretation 1 january 2016 chief executive officer chief operating decision maker responsible allocating resource annual improvement ifrs standard 20122014 assessing performance operating segment amendment ia 1 part iasb project disclosure initiative amendment clarify guidance materiality aggregation presentation subtotal structure financial oriolakds operating reporting segment 1 january 2016 consumer service statement disclosure accounting policy healthcare amendment ia 16 property plant equipment ia 38 intangible asset clarification acceptable method depreciation amortization amendment forbids use revenue asset liability reporting segment include item directly attributable based method depreciation amortisation tangible intangible asset amendment segment item allocated segment group item include financial item impact consolidated financial statement well item related corporate function amendment ifrs 11 joint arrangement accounting acquisition interest joint opera geographical area oriolakd finland sweden baltic country tions amendment requires acquirer interest joint operation activity country net sale divided country customer located asset constitutes business apply principle business combination accounting amendment investment divided according country located impact consolidated financial statement new esma european security market authority guideline alternative performance measure apms effective financial year 2016 oriolakd present apms reflect underlying business performance enhance comparability financial period apms considered substitute measure performance accordance ifrs q1 2016 oriolakd relabels previously referenced excluding nonrecurring item adjusted reporting segment operating profit reported excluding adjustment item addition oriolakd us invoicing measure accounting principle use estimate describe business volume oriolakd business environment strategy business area case corporate governance financial statement 48 financial statement adjustment ebitda operating profit exclude gain loss sale 414 reporting segment discontinuation business operation asset gain loss restructuring business operation impairment loss goodwill noncurrent asset income eur million oriolakd year 2016 expense arising rare event change estimate regarding realization health group group 2016 note consumer service care item total contingent consideration arising business acquisition oriolakds agreement pharmaceutical company either wholesale agreement external invoicing 8115 25721 363 34200 oriolakd buy product stock agreement oriolakd delivers internal invoicing 00 3624 3624 product consignment stock oriolakd report invoicing type invoicing 411 8115 29346 363 3624 34200 agreement describes volume business sale external 411 invoicing customer 7925 8134 362 16421 sale eur million 2016 2015 segment 00 3624 3624 net sale 421 7925 11758 362 3624 16421 net sale 16421 16263 acquisition cost consignment stock 17572 16170 operating profit 328 336 76 01 588 cash discount 206 188 adjusted operating profit 334 347 10 60 611 invoicing 34200 32622 asset 4539 3406 445 864 9254 liability 739 5041 58 1364 7203 412 adjusted ebitda adjusted operating profit investment 511531 174 146 445 122 888 depreciation adjusted ebitda impairment 511531 171 57 90 03 322 eur million 2016 2015 operating profit 588 626 average number personnel 1638 822 80 42 2582 depreciation impairment 322 226 ebitda 910 851 2015 adjusting item included ebitda 42 18 external invoicing 7944 24678 32622 adjusted ebitda 868 834 internal invoicing 00 3342 3342 invoicing 411 7944 28020 3342 32622 adjusted operating profit eur million 2016 2015 sale external customer 7771 8492 16263 operating profit 588 626 sale adjusting item included operating profit 22 18 segment 00 3342 3342 adjusted operating profit 611 608 net sale 421 7771 11834 3342 16263 413 adjusting item operating profit 337 322 34 626 adjusted operating profit 337 332 61 608 adjusting item included operating profit asset 4541 3601 1326 9469 eur million 2016 2015 liability 762 5444 1316 7523 restructuring cost 14 14 investment 511531 125 50 29 204 impairment 64 depreciation revaluation contingent consideration 63 34 impairment 511531 166 57 02 226 pension 03 07 01 average number personnel 1550 739 38 2327 total 22 18 oriolakd business environment strategy business area case corporate governance financial statement 49 financial statement 415 geographical information 42 operating income eur million revenue recognition group net sale include income sale good sale oriolakd year 2016 baltic group service adjusted indirect tax discount currency translation difference resulting 2016 sweden finland country country total sale foreign currency income sale good recognised major risk sale external customer 11431 3725 507 758 16421 reward ownership good transferred buyer income service asset 6641 2421 192 01 9254 recognised service performed contract based consignment inventory investment 447 439 02 888 logistics service fee recognised net sale average number personnel 1927 498 157 1 2582 group retail pharmacy sell pharmaceutical healthcare product sale good recognised company sell product customer sale adjusted estimated future bonus discount loyalty programme retail sale usually cash credit card sale 2015 consumer sale external customer 11244 3857 457 706 16263 service comprise various expert service provided pharmaceutical company pharmacy asset 6569 2714 186 9469 county council private health care provider sale service recognised period investment 136 64 04 204 service performed average number personnel 1800 372 155 2327 421 net sale currency invoicing 5 year 2016 2015 4000 eur million sek eur sek eur eur million 3500 sweden 114981 12143 111306 11900 3000 3420 finland 3738 3873 3262 3074 3060 2500 2951 baltic 540 490 2000 total 16421 16263 1500 1000 422 operating income 500 0 eur million 2016 2015 2012 2013 2014 2015 2016 gain sale tangible intangible asset 00 02 rental income 03 03 service charge 02 02 marketing contribution 113 102 revaluation contingent consideration 66 34 operating income 18 06 total 202 149 operating income consists mainly marketing contribution retail campaign accounting principle oriolakd business environment strategy business area case corporate governance financial statement 50 financial statement 423 trade receivables material item included prepaid expense accrued income trade receivables trade receivables carried anticipated realisable value eur million 2016 2015 oriolakd year 2016 original invoice amount less estimated valuation allowance impairment receivables income tax receivable 90 33 valuation allowance impairment trade receivables recognised objective compensation received 01 02 evidence group able collect amount due according original term receivables 20 104 receivables trade receivables classified accordance ifrs 7 loan receivables total 111 139 eur million 2016 2015 43 operating expense trade receivables 1926 1940 prepaid expense accrued income 111 139 431 cost good sold derivative measured fair value profit loss 01 01 vat receivables 90 90 cost good sold cost good sold includes material procurement cost related rental prepayment guarantee 41 33 manufacturing procurement prepaid expense 72 66 receivables 38 06 total 2280 2275 eur million 2016 2015 purchase period 12902 13148 part managing liquidity risk oriolakd openended frame agreement sweden change inventory 17 161 allow company sell trade receivables relating swedish retail wholesale product use 03 03 business financial institution nonrecourse basis sold nonrecourse trade receivables foreign exchange difference 00 00 eur 1185 1146 million balance sheet date significant change anticipated cost good sold 12916 12984 scope programme 2017 credit risk finland reduced interestbearing advance payment pharmacy cost good sold currency 2016 interestbearing advance payment presented current interestbearing liability million sek eur balance sheet balance sheet date prepayment amounted eur 215 239 sweden 89371 9438 million finland 3046 baltic 431 aging impairment trade receivables closing date total 12916 2016 2015 eur million gross impairment gross impairment 2015 million sek eur past due 1844 1857 past due 130 day 74 81 sweden 87359 9340 past due 31180 day 08 02 finland 3259 past due 180 day 01 00 01 01 baltic 386 total 1927 00 1941 01 total 12984 book value trade receivables corresponds maximum amount credit risk relating balance sheet date accounting principle oriolakd business environment strategy business area case corporate governance financial statement 51 financial statement 432 inventory 441 employee benefit inventory inventory presented consolidated statement financial position lower eur million 2016 2015 oriolakd year 2016 cost net realisable value net realisable value estimated selling price ordinary wage salary bonus 1038 953 course business less estimated cost completion estimated necessary direct cost sharebased payment sale cost inventory determined basis fifo principle settlement cash 03 03 payment share 03 03 inventory 31 december 2016 eur 1994 2011 million finished good pension cost pharmaceutical health related product financial year 2016 material defined contribution plan 339 314 inventory writeoffs recognized defined benefit plan 05 20 eur million 2016 2015 personnel expense 157 146 total 1545 1438 raw material consumables 01 00 work progress 05 03 employee per business area yearend finished good 1987 2007 total 1994 2011 0 35 120 45 745 989 433 operating expense consumer service eur million 2016 2015 2015 2016 healthcare freight variable cost 254 229 group administration marketing 127 146 1574 1668 information management 146 148 premise 284 263 external service 165 126 employee per country yearend operating expense 276 228 159 152 total 1252 1139 364 705 sweden 44 employee benefit 2015 2016 finland baltic pension benefit group pension arrangement compliance country local regulation practice pension arrangement group company comprise defined 1831 1964 contribution plan defined benefit plan payment defined contribution plan recognised expense income statement period incur defined benefit pension plan group obligation limited payment made plan also includes actuarial investment risk related pension plan question pension expense related defined benefit calculated using projected unit credit method pension expense recognised expense distributing estimated period service personnel concerned amount pension obligation present value estimated future pension payable accounting principle oriolakd business environment strategy business area case corporate governance financial statement 52 financial statement 442 postemployment benefit change defined benefit obligation plan ssets oriolakd defined benefit pension plan finland sweden group baltic present subsidiary defined benefit pension plan value fair value oriolakd year 2016 31122015 asset liability relating tyelpension oriolakds funded plan personnel finland transferred mutual pension insurance company ilmarinen eur million obligation asset total supplementary pension management insurance portfolio op life assurance 1 jan 2015 793 645 149 plan transferred connection liquidation oriola pension fund current service cost 21 02 19 2017 finland adopt pension reform oriolakd decided compensate interest cost income 20 16 04 deficit due change pension act supplementary pension plan gainslosses curtailment settlement 635 632 03 sweden office employee covered defined benefit plan itp 2 199 31 168 others defined contribution plan itp 1 employee defined contribution remeasurements plan according local legislation itp 2 company recognize old age pension actuarial gain loss arising change demographical assumption 17 00 17 liability statement financial position alternatively pay pension expense actuarial gain loss arising pension insurance company alecta oriola ab recognized itp 2 old age pension change financial assumption 92 00 92 liability full statement financial position oriola ab old age pension benefit experience profit loss 17 03 19 itp 2 insured alecta kronans droghandel apotek ab pension benefit 141 28 112 based defined contribution insured alecta difference foreign exchange rate 02 00 02 employer contribution postemployment benefit plan expected eur 04 contribution million 2017 financial year weighted average duration defined benefit employer 00 15 15 obligation 213 year plan participant 00 00 00 group also operates longservice benefit scheme longservice benefit scheme expense arising plan presented noncurrent liability statement financial position benefit paid 20 20 00 mortality assumption made basis actuarial guideline founded 31 dec 2015 118 23 96 statistic published region experience current service cost 04 04 sensitivity defined benefit obligation change significant assumption interest cost income 04 01 03 126 23 103 net defined benefit liability statement financial position defined follows remeasurements actuarial gain loss arising eur million 2016 2015 change financial assumption 13 03 10 present value funded obligation 130 118 experience profit loss 05 05 fair value plan asset 24 23 135 27 108 deficitsurplus 106 96 expense arising plan benefit paid 04 02 02 net liability asset statement financial position 106 96 31 dec 2016 130 24 106 accounting principle oriolakd business environment strategy business area case corporate governance financial statement 53 financial statement significant actuarial assumption 31 dec 2016 2015 executive incentive plan 20132015 discount rate 1328 2526 19 december 2012 oriolakds board director approved sharebased incentive plan salary increase 1625 2022 group executive target group new plan performance period oriolakd year 2016 2015 consisted six participant plan included three performance period calendar effect defined benefit pension obligation year 2013 2014 2015 company board director decided earning criterion change earning period target set start earning period assumption effect change potential reward plan performance period 2015 based oriolakd percentage assumption group earnings per share eps reward paid basis performance assumption point period 2015 correspond value approximate maximum total 247541 decrease discount rate 05 increase 115 company class b share also including proportion paid cash reward increase discount rate 05 reduce 101 paid executive employment service group company end reward increase salary 05 increase 50 payment 2018 payment based performance period 2014 since increase benefit 05 increase 116 performance criterion plan met expense recognised incentive plan eur 03 02 million 2016 table present sensitivity analysis significant actuarial assumption showing effect change actuarial assumption defined benefit pension executive incentive plan 20162018 obligation 2 december 2015 board director oriolakd corporation resolved establish effect sensitivity analysis calculated effect new sharebased incentive plan directed group key personnel approximately 20 change assumption calculated assumption expected remain key person including member group management team participate plan unchanged unlikely happen assumption change may correlate plan includes three performance period calendar year 2016 2017 2018 three sensitivity defined benefit obligation calculated using vesting period calendar year 2017 2018 2019 respectively board director method calculation pension obligation entered statement company resolve plan performance criterion required performance financial position current value defined benefit obligation end level criterion beginning performance period potential reward reporting period using projected unit credit method performance period 2016 based group earnings per share eps significant risk arising defined benefit pension plan plan reward paid basis performance period 2016 correspond value obligation connected generating lifelong benefit employee reason approximate maximum total 800000 company class b share also including higher life expectancy mean obligation plan proportion paid cash potential reward paid 2018 prerequisite use estimate discounted value pension obligation based several actuarial participation plan receipt reward basis plan key assumption change assumption impact carrying amount pension person enrolled okshares make monthly saving fixed gross obligation discount rate used one assumption used interest rate used determined monthly salary accordance rule okshares force member date measurement reference maturity corporate bond issued financially sound group management team must hold 50 per cent net share given basis company similar pension obligation key assumption impacting pension entire plan shareholding company total equal value liability based circumstance valid time gross annual salary expense recognised incentive plan eur 01 million 2016 443 sharebased payment share saving plan sharebased payment share incentive plan measured fair value grant date accordance ifrs 2 recognised expense within vesting period equitysettled 18 june 2015 board director oriolakd corporation decided launch key component recognised equity cashsettled payment liability fair value personnel share saving plan saving period began 1 october 2015 ended cashsettled component remeasured balance sheet date end vesting period 31 december 2016 maximum monthly saving 83 percent minimum 2 fair value liability adjusted accordance oriolakd corporation share price percent participant fixed monthly gross salary total 50 key employee participated plan expense recognised share saving plan eur 01 02 million 2016 accounting principle use estimate oriolakd business environment strategy business area case corporate governance financial statement 54 financial statement 444 management benefit 45 leasing contract president ceo group management team leasing lease agreement transfer significant proportion risk reward related oriolakd year 2016 eur thousand 2016 2015 2016 2015 ownership asset group classified finance lease agreement finance lease basic salary 4957 4427 15935 13126 agreement recorded consolidated statement financial position asset bonus 1632 1849 2263 3434 liability inspection lease lower fair value asset present value pension expense statutory 1230 1074 3800 2987 minimum lease payment asset acquired finance lease depreciated similarly noncurrent asset pension expense voluntary 631 439 shorter useful life asset lease term finance lease liability recorded total 7819 7350 22629 19986 noncurrent current liability consolidated statement financial position risk reward associated ownership asset remain lessor total salary president ceo group group management team lease agreement treated operating lease resulting lease payment recognized include supplementary health insurance expense entire lease term president ceo group group management team participate statutory pension scheme 451 group lessee two group management team member participate voluntary defined contribution oriolakd significant portfolio lease contract pharmacy sweden usual plan duration lease 3 year regularly renewed next lease period 19 new lease signed 2016 5 lease contract expired group also leased 445 salary benefit member board director equipment eur thousand 2016 2015 committed future minimum lease payment anssi vanjoki chairman 1 594 599 jukka alho 2 15 413 eur million 2016 2015 harry brade 3 28 within one year 185 157 eva nilsson bågenholm vice chairman 1 388 302 one five year 346 180 per båtelson 4 10 303 five year 70 69 anja korhonen 408 437 total 601 407 mariette kristenson 4 297 kuisma niemelä 322 338 group leased office warehouse retail premise fixedterm lease contract lena ridström 4 297 partly right renew lease leasing expense eur 205 185 million matti rihko 307 318 staffan simberg 1 322 322 46 provision total 2959 3059 provision provision recognised consolidated statement financial position 1 30 march 2015 group present legal contractual obligation result past event probable outflow resource embodying economic benefit required settle obligation 2 chairman 30 march 2015 member 14 march 2016 reliable estimate made amount obligation 3 30 march 2015 restructuring provision recognised group detailed formal restructuring plan 4 14 march 2016 started implementation plan informed affected plan provision related cost continuing operation recognised board director annual fee 60 per cent paid cash 40 per cent company class b share provision recognized 2016 apportionment paid share expense eur 01 01 million recognised 2016 accounting principle oriolakd business environment strategy business area case corporate governance financial statement 55 financial statement 47 audit fee 49 operating profit 471 audit fee operating profit operating profit determined net sale less cost good sold less sale oriolakd year 2016 distribution expense less administrative expense operating expense less depreciation eur million 2016 2015 amortisation plus operating income foreign exchange difference change fair member firm pricewaterhousecoopers oy network value derivative recognised operating profit provided arise item related business operation otherwise recognised within financial item audit related service 03 02 tax nonaudit service 00 01 total 04 03 5 tangible intangible asset leasing 48 trade payable liability arrangement depreciation amortisation 481 trade payable current liability 51 property plant equipment eur million 2016 2015 tangible asset tangible asset initially recognised historical cost subsequently trade payable 5043 5477 measured historical cost less depreciation impairment loss asset depreciated accrued liability deferred income 425 393 estimated useful life using straightline method useful life asset reviewed least derivative designated hedge 06 annually adjusted necessary estimated useful life follows derivative fair value profit loss 13 current liability 96 75 building 2050 year total 5570 5959 machinery equipment 510 year tangible asset 10 year material item included accrued liability deferred income intangible asset 320 year eur million 2016 2015 land area subject depreciation repair maintenance cost recognised expense period improvement investment capitalised providing expected accrued wage salary social security payment 192 190 generate future economic benefit gain loss resulting disposal tangible asset income tax liability 141 117 recognised operating profit accrued liability deferred income 92 87 total 425 393 482 noncurrent liability eur million 2016 2015 derivative designated hedge 03 16 contingent consideration 27 noncurrent liability 1 04 05 total 34 21 1 noncurrent liability consist longservice benefit liability accounting principle oriolakd business environment strategy business area case corporate governance financial statement 56 financial statement 511 property plant equipment advance eur million payment oriolakd year 2016 building machinery tangible construction 2016 land water construction equipment asset 1 progress total historical cost 1 jan 2016 20 505 803 288 27 1644 business combination 19 00 19 increase 06 81 36 37 160 decrease 01 28 72 03 00 104 reclassification 02 08 10 21 00 foreign exchange rate difference 00 05 22 11 01 39 historical cost 31 dec 2016 19 481 817 321 43 1680 accumulated depreciation 1 jan 2016 326 507 83 917 accumulated depreciation related decrease reclassification 15 67 02 84 depreciation financial year 17 106 29 152 foreign exchange rate difference 03 14 03 20 accumulated depreciation 31 dec 2016 326 532 107 965 carrying amount 1 jan 2016 20 179 296 205 27 727 carrying amount 31 dec 2016 19 155 285 213 43 715 2015 historical cost 1 jan 2015 20 498 758 248 15 1538 increase 04 63 35 17 119 decrease 35 00 35 reclassification 00 05 00 05 00 foreign exchange rate difference 00 03 13 05 00 21 historical cost 31 dec 2015 20 505 803 288 27 1644 accumulated depreciation 1 jan 2015 308 422 57 786 accumulated depreciation related decrease reclassification 29 00 29 depreciation financial year 17 106 25 148 foreign exchange rate difference 02 08 02 11 accumulated depreciation 31 dec 2015 326 507 83 917 carrying amount 1 jan 2015 20 190 336 191 15 752 carrying amount 31 dec 2015 20 179 296 205 27 727 1 significant share tangible asset made refurbishment expenditure rented premise accounting principle oriolakd business environment strategy business area case corporate governance financial statement 57 financial statement 52 finance lease 522 maturity finance lease liability finance lease lease agreement transfer significant proportion risk reward eur million 2016 2015 oriolakd year 2016 related ownership asset group classified finance lease agreement finance within one year 13 17 lease agreement recorded consolidated statement financial position asset within 15 year 14 16 liability inspection lease lower fair value asset present value unearned financial expense 00 01 minimum lease payment total 27 32 asset acquired finance lease depreciated similarly noncurrent asset shorter useful life asset lease term finance lease liability recorded present value minimum lease payment noncurrent current liability consolidated statement financial position eur million 2016 2015 asset leased finance lease agreement consist mainly information within one year 15 16 communication technology equipment within 15 year 12 16 521 asset leased finance lease agreement total 27 32 tangible asset include following asset leased finance lease agreement 53 intangible asset goodwill 1 january 2010 goodwill arising business combination recognised eur million machinery amount aggregate fair value consideration transferred acquisition 2016 equipment total date fair value previously held interest noncontrolling interest exceeds fair value net asset acquired historical cost 77 77 goodwill amortised tested impairment least annually purpose accumulated depreciation 51 51 impairment testing goodwill allocated cashgenerating unit goodwill measured cost less carrying amount 27 27 accumulated impairment loss impairment loss recognised income statement 2015 intangible asset intangible asset initially recognised historical cost historical cost 99 99 subsequently measured historical cost less depreciation impairment loss ntangible accumulated depreciation 68 68 asset include sale licence trademark patent software licence product marketing right carrying amount 31 31 asset finite useful life depreciated useful life using straightline method also research development cost normally expensed operating expense reporting period incurred expenditure development capitalised relates new product service technically commercially feasible majority group development expenditure meet criterion capitalisation recognised expense incurred accounting principle oriolakd business environment strategy business area case corporate governance financial statement 58 financial statement 531 intangible asset eur million advance payment intangible construction oriolakd year 2016 2016 goodwill intangible right asset 1 progress total historical cost 1 jan 2016 2565 919 60 29 3572 business combination 15 01 16 increase 451 110 09 123 692 decrease 02 00 00 02 reclassification 01 01 00 foreign exchange rate difference 84 34 00 117 historical cost 31 dec 2016 2932 1009 69 151 4161 accumulated amortisation 1 jan 2016 345 31 376 accumulated amortisation related decrease reclassification 01 00 02 amortisation financial year 93 12 105 impairment 64 64 foreign exchange rate difference 13 13 accumulated amortisation 31 dec 2016 64 424 43 531 carrying amount 1 jan 2016 2565 574 29 29 3197 carrying amount 31 dec 2016 2868 585 27 151 3630 2015 historical cost 1 jan 2015 2509 857 56 09 3431 increase 56 05 25 85 decrease 16 01 17 reclassification 04 01 05 00 foreign exchange rate difference 55 18 00 74 historical cost 31 dec 2015 2565 919 60 29 3572 accumulated amortisation 1 jan 2015 287 21 308 accumulated amortisation related decrease reclassification 16 01 17 amortisation financial year 67 11 78 foreign exchange rate difference 07 07 accumulated amortisation 31 dec 2015 345 31 376 carrying amount 1 jan 2015 2509 570 34 09 3123 carrying amount 31 dec 2015 2565 574 29 29 3197 1 intangible asset include significant expense installation specialist work related implementation computer software accounting principle oriolakd business environment strategy business area case corporate governance financial statement 59 financial statement 532 allocation impairment testing goodwill projection parameter applied impairment tangible intangible asset group assesses reporting date whether posttax pretax oriolakd year 2016 indication asset may impaired indication exists group estimate discount discount operating terminal net sale asset recoverable amount recoverable amount higher net sale price value use 2016 rate rate profit 1 growth 2 growth 3 present value expected future cash flow expected derived asset consumer baltic 65 82 36 30 92 impairment loss recognised income statement carrying amount asset consumer sweden 71 91 61 20 28 exceeds recoverable amount impairment loss reversed change circum stance recoverable amount exceeds carrying amount reversal impairment loss service sweden 71 91 16 20 103 cannot exceed asset carrying amount without impairment loss healthcare sweden 71 91 20 20 38 goodwill impairment test conducted least annually frequently healthcare finland 65 82 115 20 15 indication goodwill may impaired impairment recognised income statement service finland 65 82 46 20 59 depreciation impairment goodwill impairment loss reversed 2015 8 february 2016 time acquisition svensk do tender dose consumer baltic 73 91 36 20 30 dispensing sjuklövern county contract appeal decision consumer sweden 75 96 61 20 23 swedish supreme administrative court sjuklövern confirmed issue service sweden 75 96 16 20 34 new tender dose dispensing county consequently eur 64 million goodwill impairment charge recognised september 2016 1 perating profit percentage change average operating profit percentage threeyear period 2 f rom beginning year 2020 goodwill allocated follows 3 cagr fiveyear period eur million 2016 2015 change projection parameter cause fair value equal book value 4 consumer 2252 2305 service 337 260 operating healthcare 280 discount profit terminal net sale carrying amount 2868 2565 rate change percentage growth growth 2016 change change change consumer baltic 71 19 98 190 consumer sweden 40 17 57 77 service sweden 275 14 295 healthcare sweden healthcare finland 10 19 12 403 service finland 40 20 53 496 2015 consumer baltic 171 26 146 consumer sweden 20 28 87 133 service sweden 285 14 1147 4 greater change parameter would result partial impairment goodwill providing key assumption remain unchanged accounting principle oriolakd business environment strategy business area case corporate governance financial statement 60 financial statement recoverable amount cashgenerating unit determined impairment testing 6 capital structure financing cost basis valueinuse calculation valueinuse determined based discounted cash flow dcfmodel cash flow forecast based threeyear strategic 61 financing cost oriolakd year 2016 plan approved management consistent current business structure important assumption strategic plan estimate overall longterm interest income expense interest income expense recognised timeproportion growth market market position well profitability group basis using effective interest method business foreign exchange rate used converting calculation euro prevailing time testing average interest rate interestbearing liability 126 150 per cent main parameter used impairment testing net sale growth percentage ebit percentage terminal growth percentage discount rate 611 financial income expense threeyear net sale forecast based management assessment net eur million 2016 2015 sale growth market development forecast available external information source ims sale growth based group action financial income terminal growth rate used calculation based management assess interest income loan receivables 03 02 ments longterm growth cash flow estimating terminal growth rate interest income financial asset liability recognised fair value 01 countryspecific business sector growth forecast available external information foreign exchange rate gain loan receivables net 08 19 source well characteristic feature operating segment cash generating financial income 00 00 unit taken account terminal growth rate used baltic cash generating unit total 11 22 30 per cent year 2020 growth rate estimate baltic country external information source ims health 20152019 14 per cent terminal growth financial expense rate swedish cash generating unit 20 per cent year 2020 growth interest expense financial asset liability recognised rate estimate external information source ims health 20152020 average 42 fair value 01 per cent interest expense interest rate swap hedge accounting 12 10 discount rate used calculation based group weighted average cost interest expense financial liability amortized cost 28 40 capital taking account industry country specific risk group foreign exchange rate loss financial asset liability operating segment important component defining discount rate recognised fair value net 08 23 longterm riskfree interest rate operating country riskfree interest rate used financial expense 09 14 finland baltic cash generating unit 05 16 per cent riskfree interest rate total 58 87 swedish cash generating unit 11 18 per cent defining discount rate oriolakd acquired necessary information external information source financial income expense total 47 65 use estimate group asset indefinite useful life subject annual impairment testing 62 financial asset liability indication impairment asset assessed described accounting principle recoverable value used impairment testing discounted future cash flow obtained financial asset liability financial asset liability oriolakd group classified usage possible sale asset carrying amount asset exceeds either accordance standard ia 39 financial instrument recognition measurement recoverable amount fair value difference recognised impairment charge preparation follows calculation requires use estimate financial asset liability recognised fair value profit loss loan receivables availableforsale financial asset financial liability recognised amortised cost classification take place inception based purpose acquisition financial asset liability financial instrument recognised consolidated statement financial position settlement date money market investment derivative classified held trading meet ia 39 criterion hedge accounting recorded financial asset liability recognised accounting principle use estimate oriolakd business environment strategy business area case corporate governance financial statement 61 financial statement fair value profit loss asset within category shortterm asset maturity debtor bankruptcy failure pay significant delay payment considered less 12 month measured fair value using market price balance sheet date justified reason impairment trade receivables impairment recognised expense realised unrealised gain loss arising change fair value recognised consolidated statement comprehensive income sold nonrecourse trade receivables credit risk oriolakd year 2016 consolidated statement comprehensive income financial period contractual right transferred group selling date related expense incurred financial asset derecognised group loses right receive contractual recognised financial expense cash flow financial asset transfer substantially risk reward ownership availableforsale financial asset nonderivative financial asset expressly classified outside group within category cannot classified category included cash cash equivalent consist cash hand cash bank account noncurrent financial asset balance sheet unless intention sell asset loan receivables nonderivative financial asset payment fixed 12 month period following balance sheet date determinable receivables quoted active market group hold financial liability recognised amortised cost recognised consolidated statement trading purpose measured amortised cost receivables classified current financial position net value received date acquisition transaction cost included financial asset unless maturity date 12 month balance sheet date trade original carrying amount borrowing financial liability subsequently measured receivables also included category trade receivables recognised amortised cost using effective interest method interest expense recognised income original book value valuation allowance impairment trade receivables recognised statement using effective interest method borrowing expire within 12 month objective evidence group able collect amount due according balance sheet date including bank overdraft use recorded within current borrowing original term receivables significant financial difficulty debtor probability expiring period exceeding 12 month recorded within noncurrent borrowing 621 financial asset liability 2016 2015 eur million note fair value book value fair value book value financial asset recognised fair value profit loss derivative measured fair value profit loss 423 01 01 01 01 loan receivables cash equivalent 624 608 608 1219 1219 trade receivables receivables 423 2099 2099 2274 2274 financial asset total 2708 2708 3494 3494 derivative designated hedge 481482 09 09 16 16 noncurrent liability 482 04 04 05 05 financial liability recognised fair value profit loss derivative measured fair value profit loss 481 13 13 contingent consideration 482625 27 27 124 124 financial liability measured amortised cost noncurrent interestbearing liability 625 846 846 669 669 current interestbearing liability 625 485 485 493 493 trade payable current liability 481 5423 5423 5945 5945 financial liability total 6794 6794 7265 7265 accounting principle oriolakd business environment strategy business area case corporate governance financial statement 62 financial statement 622 fair value hierarchy 624 cash cash equivalent eur million eur million 2016 2015 oriolakd year 2016 2016 level 1 level 2 level 3 total cash cash equivalent 608 1219 asset total 608 1219 derivative measured fair value profit loss 01 01 625 borrowing liability derivative designated hedge 09 09 noncurrent contingent consideration 27 27 eur million 2016 2015 loan financial institution 834 653 2015 finance lease liability 12 16 asset total 846 669 derivative measured fair value profit loss 01 01 current liability eur million 2016 2015 derivative designated hedge 16 16 loan financial institution 105 109 derivative measured fair value issued commercial paper 150 130 profit loss 13 13 advance received 215 239 contingent consideration 124 124 finance lease liability 15 16 contingent consideration 1 124 level 1 quoted price unadjusted active market identical asset liability total 485 617 level 2 input quoted price included within level 1 observable 1 contingent consideration fair value additional information note 621 asset liability either directly ie price indirectly ie derived price level 3 input asset liability based observable market data ie maturity noncurrent interestbearing liability unobservable input eur million 2016 2015 623 reconciliation financial liability recognised fair 15 year 846 669 value profit loss according level 3 five year total 846 669 eur million 2016 2015 carrying amount 1 jan 124 147 interestbearing liability currency booking financial expense 02 09 eur million 2016 2015 decrease fair value recognised financial liability 219 34 eur 678 371 increase fair value recognised financial liability 119 sek 653 915 translation difference 01 02 total 1331 1286 carrying amount 31 dec 27 124 maturity structure interestbearing liability financial liability recognised fair value profit loss level 3 include 60 eur million estimated value contingent deferred consideration acquisition fair value contingent consideration calculated using discounted cash flow method 50 533 487 discount rate used valuation determined using weighted average cost capital 40 group decrease fair value financial liability relates payment 30 contingent consideration related medstop acquisition 306 20 10 06 0 2017 2018 2019 2020 oriolakd business environment strategy business area case corporate governance financial statement 63 financial statement 626 contingent liability translation risk oriolakds significant translation risk concern item swedish krona translation risk arise capital investment goodwill foreign subsidiary eur million 2016 2015 balance sheet date oriolakd hedged equityrelated translation risk oriolakd year 2016 commitment liability balance sheet date swedish krona denominated translation risk position eur 2402 2319 guarantee behalf company 83 85 million guarantee behalf company 10 20 currency risk sensitivity analysis effect 10 per cent weakeningstrengthening mortgage company asset 34 23 swedish krona would affect oriolakds earnings tax eur 0304 million guarantee liability 10 10 group equity eur 218 211 million total 136 137 liquidity risk objective liquidity risk management maintain adequate liquid asset revolving credit facility oriolakd able meet financial guarantee behalf company relate sold russian entity guarantee obligation group liquidity management based 12month cash flow forecast behalf company expired 31 december 2016 fourweek rolling cash flow forecast drawn weekly basis oriolakd diversified significant guarantee bank guarantee trade payable refinancing risk among number different counterparties various financing source subsidiary sweden addition oriolakd corporation granted parent company oriolakds liquidity position secured eur 100 100 million committed credit facility guarantee eur 27 28 million subsidiary trade payable expires 2018 shortterm uncommitted credit account limit eur 152 354 million facility unused balance sheet date addition oriolakd eur 63 financial risk management 200 200 million uncommitted commercial paper programme eur 150 130 million financial risk relating business operation oriolakd managed accordance issued balance sheet date oriolakds cash cash equivalent total treasury policy approved board director oriolakds centralized group eur 608 1219 million treasury responsible implementing monitoring reporting treasury policy oriolakds net working capital eur 1122 1526 million balance sheet date oriolakds group treasury main objective maintain solid longterm financial oriolakds net working capital negative balance sheet date owing term position secure daily liquidity group efficiently manage currency payment defined principal customer agreement nonrecourse factoring interest rate risk programme used retail wholesale business sweden group principal objective financial risk management hedge unfavourable change customer agreement based established longterm agreement significant financial market minimise impact foreign exchange interest rate refinancing change anticipated 2017 liquidity risk group cash reserve profit shareholder equity approved oriolakd openended frame agreement sweden allows company hedging instrument set treasury policy sell trade receivables relating swedish retail wholesale business financial currency risk important countryspecific operating currency oriolakd institution nonrecourse basis presented within trade receivables sale trade euro eur swedish krona sek substantial proportion procurement receivables eur 1185 1146 million total balance sheet date significant sale conducted reporting currency subsidiary considerably reduces change anticipated scope program 2017 currency risk accordance treasury policy oriolakds internal loan deposit denominated local currency subsidiary gearing transaction risk transaction risk arise commercial financerelated transaction payment made business unit denominated currency 918 100 gearing unit reporting currency due nature business operation oriolakds transaction 90 risk minor accordance treasury policy oriolakds internal loan deposit 80 70 653 denominated local currency subsidiary mainly swedish krona addition 60 oriolakd corporation eur 628 915 million swedish krona denominated external loan 50 352 balance sheet date accordance treasury policy aim fully hedge 40 transaction risk arising balance sheet item recognized income statement 30 20 derivative balance sheet date swedish krona denominated transaction position 10 0 21 34 eur 12 48 million 2012 2013 2014 2015 2016 accounting principle oriolakd business environment strategy business area case corporate governance financial statement 64 financial statement interest rate risk interest rate risk arises change interest payment floating added net debt adjusted gearing addition oriolakds aim pay rate loan due change market interest rate market value change financial increasing annual dividend least 50 per cent earnings per share instrument price risk objective interest rate risk management minimise oriolakds longterm financing agreement include financial covenant term based oriolakd year 2016 impact interest rate fluctuation income statement interest rate risk evaluated ratio net debt ebitda gearing ratio balance sheet date using sensitivity analysis interest rate duration financial covenant clearly fulfilled balance sheet date oriolakds interest rate risk consisted eur 608 1219 million financial ratio related capital management presented financial indicator cash asset eur 1331 1286 million interestbearing liability eur 1185 1146 million sale nonrecourse trade receivables sweden balance sheet date total 631 maturity distribution financial liability derivative liability eur 544 567 million interest rate risk hedged average interest rate liability including sale receivables nonrecourse basis 126 15 per cent 31 dec 2016 interest rate duration 5 7 month cash flow hedge accounting applied interest eur million 2017 2018 2019 2020 total rate hedging interestbearing based gross debt balance sheet date assuming trade receivables loan financial institution sale programme continue normal sweden effect one percentage point commercial paper loan 266 531 305 04 1106 increase market interest rate group annual earnings tax would eur 09 finance lease liability 13 09 04 01 27 11 million including derivative equity eur 06 12 million including derivative advance payment received 219 219 credit counterparty risk credit risk arises possibility counterparty noninterestbearing failing meet contractual payment obligation financial institution failing meet trade payable current liability 5570 5570 obligation relating deposit derivative trading oriolakds treasury policy provides liability interest rate swap 06 03 09 framework credit investment counterparty risk management contingent consideration 27 27 credit limit determined investment derivative agreement counterparties receivables foreign currency basis creditworthiness solidity monitored updated regular basis derivative 120 120 business area responsible credit risk management arising commercial payable foreign currency derivative 121 121 receivables oriolakd significant credit risk trade receivables due total 6076 540 312 31 6960 widely diversified customer base finnish swedish wholesale business based wellestablished customer relationship contractual term generally observed within 31 dec 2015 industry significantly reduces credit risk associated trade receivables eur million 2016 2017 2018 2019 total due nature operation significant credit risk associated interestbearing swedish retail business credit risk related wholesale business finland reduced loan financial institution interestbearing advance payment pharmacy interestbearing advance commercial paper loan 259 130 550 939 payment presented current interestbearing liability balance sheet finance lease liability 17 12 04 00 34 wholesale retail business sweden credit risk reduced sale nonrecourse advance payment received 243 243 receivables financial institution usage credit loss insurance contingent consideration 124 124 credit loss recognised income statement financial year total eur 00 noninterestbearing 01 million ageing trade receivables presented detail trade trade payable current receivables liability 5959 5959 capital management oriolakds aim efficient capital structure allows liability interest rate swap 11 07 00 01 16 company manage ongoing obligation enables costeffective operation receivables foreign currency circumstance return capital employed roce gearing ratio derivative 1256 1256 measurement monitoring capital structure payable foreign currency derivative 1269 1269 oriolakds longterm financial target based growth profitability balance sheet total 6625 150 554 01 7327 key figure group longterm target grow rate market annual eps growth 5 per cent without adjusting item return capital employed 20 per cent adjusted gearing ratio 3060 per cent nonrecourse trade receivables oriolakd business environment strategy business area case corporate governance financial statement 65 financial statement 632 derivative group open foreign currency forward swap contract used cash flow hedge end 2016 derivative contract hedge accounting oriolakd recognises derivative contract accordance fair value derivative booked balance sheet gross amount oriolakd year 2016 ia 39 financial instrument recognition measurement group classified derivative derivative contract related credit event cannot netted financial derivative held trading unless hedge accounting applied fair value currency forward statement group given received collateral tofrom derivative counterparties swap contract determined measuring fair value using market rate balance sheet date positive valuation difference recognised trade receivables oriolakd derivative position several bank related transaction effected negative valuation difference recognised trade payable current liability master derivative agreement master derivative agreement allow settlement net consolidated statement financial position oriolakd applied hedge accounting currency basis outstanding item within scope agreement example event derivative hedge balance sheet item foreign currency forecasted cash flow bankcruptcy balance sheet date remaining counterparty risk net settlement change fair value derivative contract recognised either income expense allowed master derivative agreement eur 01 01 oriolakd eur 09 29 financial income expense depending underlying item hedged million counterparties oriolakd applies hedge accounting hedging cash flow relating selling nonrecourse nominal amount foreign currency derivative euro equivalent contract trade receivables fluctuating interest rate converted fixed rate using interest currency denominated amount balance sheet date rate swap initiating hedge accounting relationship hedged item hedging instrument documented along objective group risk management 64 equity share authorisation hedge effectiveness tested least quarterly change fair value effective portion derivative recognised hedge fund within equity ineffective portion treasury share treasury share acquired company related cost presented recognised within financial item deduction equity gain loss surrender treasury share recorded equity net tax eur million share capital oriolakd corporation share capital 31 december 2016 stood eur positive fair negative nominal 14789976614 issued share paid full change share 2016 value fair value value capital 2016 derivative recognised cash flow hedge hedge fund hedge fund includes effective portion change fair value interest rate swap 09 544 derivative financial instrument designated qualify cash flow hedge derivative measured fair value profit contingency fund contingency fund included unrestricted equity loss company contingency fund formed 2006 oriolakd entered foreign currency forward swap contract 01 121 trade register accordance decision annual general meeting 14 march 2016 company distribute fund shareholder 31 december 2016 2015 contingency fund stood eur 194 million derivative recognised cash flow hedge hybrid bond oriolakd redeemed eur 40 million hybrid bond issued 20 february interest rate swap 16 566 2014 entirety together accrued interest bond redeemed accordance derivative measured fair value profit term condition 20 april 2015 103 per cent nominal value 31 loss december 2016 oriolakd hybrid bond foreign currency forward swap contract 12 1269 fund derivative open balance sheet date fall due next twelvemonth period invested unrestricted equity reserve oriolakd executed directed share issue except interest rate swap recognised cash flow hedge interest rate risk relating cash payment june 2009 issuing 9350000 new class b share net proceeds received flow oriola ab selling trade receivables hedged interest rate swap share issue amounted eur 207 million proceeds share issue credited fair value interest rate derivative defined cash flow due contract reserve invested unrestricted equity accordance decision annual interest rate swap wholly designated cash flow hedge change fair value general meeting 6 april 2011 company distributed 19 april 2011 eur 013 per share related effective portion hedge recognised comprehensive income reserve invested unrestricted equity repayment equity totalling eur 197 potential ineffective part recognised income statement million fair value foreign currency forward swap contract interest rate swap fall oriolakd completed right offering first quarter 2015 subscription period due next twelve month quoted based market value balance sheet date offering ended 3 march 2015 offering 9429742 new share 20798643 new b share subscribed oriolakd raised gross proceeds eur 756 million accounting principle oriolakd business environment strategy business area case corporate governance financial statement 66 financial statement offering oriolakd recognised gross proceeds transaction cost less tax total management shareholding 31 december 2016 member company eur 737 million invested unrestricted equity fund change invested board director president ceo deputy president ceo unrestricted equity reserve 2016 fund stood eur 748 million 31 december 2016 company controlled total 443153 share corresponding 025 per cent oriolakd year 2016 translation difference translation difference include translation difference arisen total number share company 004 per cent vote subsidiary equity translation consolidation change fair value authorisation annual general meeting held 14 march 2016 authorised board net investment foreign subsidiary foreign exchange rate difference arisen director decide share issue payment one issue authorisation conversion foreign subsidiary income statement using average exchange rate comprises right issue new share assign treasury share held company reporting period conversion balance sheet using exchange rate authorisation cover maximum 5650000 class share 12500000 class b share quoted balance sheet date representing approximately 1000 per cent share company includes right share total number share company maximum 500000000 shall derogate shareholder preemptive subscription right pursuant authori class share maximum 1000000000 class b share yearend 2016 company sation share held company treasury share may also sold trading total 181486213 share 55484648 class share 126001565 regulated market organised nasdaq helsinki ltd authorisation effect period class b share share nominal value eighteen month decision agm general meeting class share carry 20 vote class b share one vote agm authorised board director decide share issue payment shareholder may vote using amount vote exceeds 120 total number vote one issue authorisation comprises right issue new class b share assign carried share different share class represented general meeting share class b treasury share held company authorisation cover combined maximum class give shareholder right company asset dividend distribution 18000000 class b share company representing approximately 992 per cent article 3 article association shareholder may demand conversion class share company includes right derogate shareholder preemptive share class b share subscription right pursuant authorisation class b share held company oriolakd corporation class b share quoted main list nasdaq treasury share may also sold regulated market organised nasdaq helsinki ltd omx helsinki exchange company field business stock exchange 31 authorisation effect period eighteen month decision agm december 2016 health care distributor company classified health authorisation revoke previous share issue authorisation given board care ticker symbol class share okdav class b share okdbv director apart authorisation given board director annual general right offering 2015 oriolakd completed right offering first quarter 2015 meeting held 20 march 2013 pursuant board director may decide upon subscription period offering ended 3 march 2015 result total number directed share issue without payment concerning 1715000 class b share oriolakd increased 181486213 share oriolakd raised gross proceeds eur 756 share order execute sharebased incentive plan oriolakd group executive million offering share saving plan oriolakd group key personnel treasury share company hold 96822 company class b share representing agm also authorised board director decide repurchasing company approximately 005 per cent total number company share approximately 001 class b share authorisation entitles board director decide per cent total number vote repurchase 18000000 company class b share representing share trading price 2016 traded volume oriolakd corporation share approximately 992 per cent share company authorisation may used excluding treasury share corresponded 134 per cent total number share way total one tenth share company may time traded volume class share amounted 34 per cent average stock time possession company subsidiary share may repurchased class b share excluding treasury share 179 per cent average stock also proportion share owned shareholder share may average share price oriolakd corporation class share eur 416 repurchased develop company capital structure execute corporate transaction class b share eur 420 market value oriolakd corporation share 31 december business arrangement finance investment used part company 2016 eur 7789 7796 million market value class share eur 2358 incentive scheme otherwise relinquished held company cancelled million class b share eur 5431 million authorisation repurchase share force period eighteen shareholder 31 december 2016 oriolakd corporation total 28558 registered month decision agm authorisation revoke authorisation given shareholder 29699406 nomineeregistered share 31 december 2016 board director agm 30 march 2015 respect repurchase company corresponding 164 per cent share 63 per cent vote class b share share conversion article 3 article association shareholder may authorisation company board director hold authorisation demand conversion class share class b share period 1 january 31 concerning share issue share option special right december 2016 conversion made accounting principle oriolakd business environment strategy business area case corporate governance financial statement 67 financial statement 641 share capital share capital share b share share total oriolakd year 2016 number share 1 jan 2016 pc 55484648 126001565 181486213 conversion share b share pc number share 31 dec 2016 pc 55484648 126001565 181486213 vote 31 dec 2016 pc 1109692960 126001565 1235694525 share capital per share class 31 dec 2016 eur million 452 1027 1479 percentage total share 306 694 1000 percentage total vote 898 102 1000 number share 1 jan 2015 pc 47148710 104109118 151257828 right issue 9429742 20798643 30228385 conversion share b share pc 1093804 1093804 number share 31 dec 2015 pc 55484648 126001565 181486213 vote 31 dec 2015 pc 1109692960 126001565 1235694525 share capital per share class 31 dec 2015 eur million 452 1027 1479 percentage total share 306 694 1000 percentage total vote 898 102 1000 eur million 2016 2015 parent company share capital 31 dec 1479 1479 elimination revaluation subsidiary share consolidated financial statement 1117 1117 consolidated share capital 31 dec 362 362 accounting principle oriolakd business environment strategy business area case corporate governance financial statement 68 financial statement 65 earnings per share dividend equity distribution earnings per share basic earnings per share calculated dividing net result attributable oriolakd year 2016 owner parent weighted shareissue adjusted average number share outstanding period excluding share acquired group held treasury share calculating diluted earnings per share weighted shareissue adjusted average number share outstanding period adjusted effect dilutive potential share eps dividend dividend equity distribution dividend equity distribution includes dividend equity distribution dividend equity distribution proposed board director recorded financial statement approved 035 eur 029 shareholder annual general meeting dividend equity distribution shareholder 030 025 recognised liability consolidated statement financial position period 024 025 dividend approved annual general meeting 020 015 dividend policy distribution proposal oriolakd seek pay increasing 015 011 014 annual dividend least 50 per cent earnings per share company strategy 010 013 009 financial position shall taken consideration determining annual dividend 005 proposal board director 0 0 payout ratio 000 board proposes annual general meeting dividend eur 014 013 per 2012 2013 2014 2015 2016 share paid 2016 651 earnings per share profit period continuing operation discontinued operation including discontinued operation eur million 2016 2015 2016 2015 2016 2015 profit attributable equity owner parent 428 445 01 428 446 total 428 445 01 428 446 average number outstanding share pc basic 181389391 177501818 181389391 177501818 181389391 177501818 diluted 181389391 177501818 181389391 177501818 181389391 177501818 earnings per share eur basic 024 025 000 024 025 diluted 024 025 000 024 025 accounting principle oriolakd business environment strategy business area case corporate governance financial statement 69 financial statement 7 consolidation included calculation gain loss sale recognised profit loss period parent company receivables foreign subsidiary considered part net investment plan repayment repayment cannot reasonably anticipated oriolakd year 2016 consolidation principle consolidated financial statement include oriolakd corporation future exchange difference arising receivables recognised consolidated directly indirectly owned subsidiary oriolakd corporation exercise control financial statement translation difference within equity control presumed exist group participation investee becomes exposed variable return entitled variable return able influence return 71 group company relatedparty transaction exercising power investee subsidiary consolidated date group gained control divested company consolidated date control lost 711 group company acquisition method used accounting elimination internal ownership intragroup transaction well intragroup receivables payable dividend unrealised group parent company internal margin eliminated group profit period attributed equity holder ownership share ownership share parent noncontrolling interest identifiable asset acquired assumed liability group company domicile vote vote acquired entity measured fair value acquisition date contingent consider parent company ation measured fair value date acquisition classified interestbearing oriolakd corporation finland liability change contingent consideration acquisitionrelated expense recognised oriola oy finland 100 100 100 100 expense income statement oriola ab sweden 100 100 100 100 share equity applicable noncontrolling interest included group equity kronans droghandel presented separately statement change shareholder equity attribution total apotek ab sweden 100 100 100 100 comprehensive income period equity holder parent noncontrolling interest svensk do ab sweden 100 100 100 100 presented within consolidated statement comprehensive income noncontrolling interest pharmaservice oy finland 100 100 100 100 measured casebycase basis either amount equal noncontrolling interest proportionate share recognised amount acquirees identifiable net asset fair farenta oy finland 709 709 709 709 value change parent ownership interest subsidiary result loss control accounted equity transaction date control lost investment retained oriola oy finland 100 100 100 100 former subsidiary recognised fair value difference recorded income oriola estonia 100 100 statement oriola eesti oü estonia 100 100 sia oriola riga latvia 100 100 foreign currency denominated item consolidated financial statement presented uab oriola vilnius lithuania 100 100 euro functional presentation currency group parent company item sia panpharmacy latvia 100 100 included financial statement subsidiary valued currency best describes financial operating condition subsidiary transaction foreign currency translated functional currencyeuro rate farenta oy 709 709 709 709 exchange prevailing date transaction monetary item translated euro farenta 1 oy finland 100 100 using rate exchange balance sheet date nonmonetary item using rate farenta 2 oy finland 100 100 exchange date transaction excluding item measured fair value farenta 3 oy finland 100 100 translated using rate exchange date valuation gain loss arising secret file oy finland 100 100 translation recognised profit loss foreign exchange gain loss operation farenta 4 oy finland 100 100 included within corresponding item operating profit foreign exchange gain loss farenta polska zpoo poland 100 100 loan denominated foreign currency included within financial income expense income statement foreign group company outside euro zone translated euro change group structure oriolakd completed acquisition svensk do ab 8 using weighted average rate exchange financial year statement financial february 2016 second quarter oriolakd established new subsidiary estonia position using rate exchange balance sheet date difference resulting carry existing brand pharmaceutical marketing business translation result period different rate income statement statement financial position recognised separate item within consolidated statement third quarter oriolakd completed acquisition pharmaservice oy comprehensive income translation difference arising acquisition cost elimination foreign acquisition approximately 71 per cent farenta oy farenta consolidated 100 per cent subsidiary translation equity item accrued acquisition date recognised oriolakd comprehensive income subsidiary sold full part related translation difference change group structure 2015 presented financial statement 2015 accounting principle oriolakd business environment strategy business area case corporate governance financial statement 70 financial statement transaction related party related party oriolakd group deemed oriolakd completed acquisition pharmaservice oy finnish company offering dose comprise member board director president ceo oriolakd dispensing supporting service 18 july 2016 pharmaservice provides supporting service corporation member group management team oriolakd group automated dose dispensing medicine pharmacy finland 2015 net sale oriolakd year 2016 immediate family aforementioned person company controlled aforemen pharmaservice approximately eur 14 million statement profit loss tioned person group significant business transaction related party statement financial position consolidated healthcare segment 18 july 2016 acquisition cost calculation based company statement financial 72 business combination position 18 july 2016 essential part prepared accordance ifrs accounting principle 721 business combination 1 september 2016 oriolakd acquired 709 per cent farenta finnish company offering service pharmaceutical company pharmacy additionally oriolakd 2016 agreed right acquire remaining share farenta net sale farenta eur million business consideration combination eur 146 million 2015 statement profit loss statement financial cash 402 position consolidated service segment 1 september 2016 contingent liability 123 acquisition cost calculation based company statement financial position total consideration 525 31 august 2016 essential part prepared accordance ifrs accounting principle recognised amount identifiable asset acquired liability 2016 oriolakd acquired eight pharmacy apotek hjärtat sweden assumed pharmacy consolidated consumer segment part kronans apotek ab property plant equipment 20 recognised goodwill acquisition eur 451 million intangible asset 76 date acquisition svensk do company tender dose deferred tax asset 05 dispensing sjuklövern county contract appeal decision inventory 22 swedish supreme administrative court sjuklövern confirmed issue trade receivables 136 new tender dose dispensing county consequently eur 64 million goodwill asset total 260 impairment charge recognised september 2016 remaining contingent liability related acquisition released profit loss amounting eur 63 million deferred tax liability 14 loan longterm liability 70 73 application new amended ifrs standard trade payable current liability 85 ifric interpretation borrowing 17 following new revised standard interpretation issued international liability total 186 accounting standard board iasb yet applied group group apply new standard interpretation effective date effective date total identifiable net asset 74 first day financial year group apply standard interpretation beginning following financial year goodwill 451 ifrs 15 revenue contract customer effective period beginning 1 january 2018 new standard replaces revenue standard interpre total 525 tations ifrs including ia 11 construction contract ia 18 revenue related interpretation oriolakd acquired swedish pharmacy company svensk do ab 8 february 2016 oriolakd made assessment effect new standard according 2015 net sale svensk do approximately eur 28 million estimated market group current assessment new standard significantly change timing share approximately 13 per cent statement profit loss statement revenue group recognise however group continue assessment financial position consolidated healthcare segment 1 february 2016 control principle 2017 evaluating whether group acting principal acquisition cost calculation based company statement financial position agent wholesale contract effect whether revenue 31 january 2016 essential part prepared accordance ifrs recorded gross basis net basis fee commission outcome evaluation accounting principle may significant effect amount revenue group record oriolakd business environment strategy business area case corporate governance financial statement 71 financial statement group continue implementation ifrs 15 2017 order ensure group appropriate system process control policy place order efficiently disclose required information oriolakd year 2016 revenue stream sale dose sale logistics wholesale retail sale dispensed good sale service service staffing service warehousing contract selling dose contract delivering contract delivering contract sale order sale pharmacy distribution service dispensed good expert service staffing service contract pharmacy private pharmaceutical pharmacy pharmaceutical customer retail consumer healthcare provider company retailer pharmaceutical company county council hospital company sale good customer sale logistics performance obligation sale good sale good delivery service sale staffing service loyalty program transportation service price good dose transaction price price good price service dispensing pharmaceutical purchase channel wholesaler production producer ifrs 9 financial instrument effective 1 january 2018 new standard replaces recognition expected credit loss sale receivables risk loss due current standard ia 39 financial instrument recognition measurement ifrs nature business low group implement new impairment process 9 modifies classification valuation financial asset contains expected fiscal year 2017 credit loss model assessing impairment financial asset instead incurred loss impairment model used ia 39 ifrs 9 risk position qualify ifrs 16 lease effective financial year beginning 1 january 2019 hedge accounting hedge accounting allowed separate risk component new standard requires lessee recognise lease liability reflecting future lease ifrs 9 relaxes requirement hedge effectiveness test requires economic payment rightofuse asset longterm lease contract group currently relationship hedged item hedging instrument hedged assessing full impact standard significant effect consumer ratio one management actually use risk management purpose segment group assessed potential impact standard standard influence classification valuation financial asset group hedging process hedge accounting continue ifrs 9 earlier ifrs 9 major effect accounting principle oriolakd business environment strategy business area case corporate governance financial statement 72 financial statement 8 note 813 tax rate reconciliation eur million 2016 2015 81 income tax oriolakd year 2016 profit tax 541 561 income tax tax expense consolidated statement comprehensive income consists corporate income tax calculated finnish tax rate 108 112 income tax based taxable profit financial year prior period adjustment change effect different tax rate foreign subsidiary 07 07 deferred tax asset liability income tax taxable profit period calculated based tax exempt income 00 00 effective income tax rate tax jurisdiction tax recognised income statement nondeductible expense 03 04 except relate item recognised directly equity comprehensive income tax previous year 00 00 tax also recognised equity comprehensive income respectively item 00 00 income tax corporate income statement 113 115 811 income tax effective tax rate 209 206 eur million 2016 2015 tax current year 99 111 tax entered positive value recognised expense tax entered tax previous year 00 00 negative value recognised income deferred tax 14 05 finnish tax rate used calculate tax 200 per cent 2016 financial total 113 115 statement 812 tax related comprehensive income eur million 82 deferred tax asset liability deferred tax calculated temporary difference carrying amount taxable 2016 tax tax effect tax value tax receivable calculated adopted taxable loss group company cash flow hedge 08 02 06 extent utilised future largest temporary difference caused actuarial gain loss 05 01 04 depreciation property plant equipment defined pension benefit plan translation difference 91 91 unused loss taxation total 88 00 88 deferred tax booked extent probably utilised future deferred tax calculated using official tax rate valid balance sheet 2015 date cash flow hedge 01 00 01 group tax loss differed tax asset recognized actuarial gain loss 56 11 44 translation difference 36 36 use estimate management estimate required determining amount recognised deferred tax asset liability appropriateness recognising deferred tax asset assessed connection total 93 12 81 preparation consolidated financial statement purpose group estimate probability subsidiary generating recoverable taxable income unused tax loss unused tax compensation utilised actual result may differ factor used estimate may lead recognition tax expense accounting principle use estimate oriolakd business environment strategy business area case corporate governance financial statement 73 financial statement 821 deferred tax asset liability eur million item booked item booked income compre business translation oriolakd year 2016 2016 1 jan statement hensive income combination difference 31 dec deferred tax asset confirmed tax loss 21 21 05 05 inventory 02 00 00 02 pension liability 01 00 01 00 02 acquisition 08 08 employee benefit 01 00 01 cash flow hedge 00 01 02 00 04 01 01 06 deferred tax asset total 37 18 00 05 00 24 deferred tax liability depreciation difference untaxed reserve 68 05 01 72 translation difference net investment 00 00 00 00 acquisition 96 09 13 02 99 05 00 03 02 deferred tax liability total 169 05 13 05 173 offset deferred tax asset 1 11 11 net deferred tax liability 158 05 00 13 05 162 2015 deferred tax asset confirmed tax loss 14 07 21 inventory 01 00 01 02 pension liability 12 00 11 01 acquisition 03 04 02 08 employee benefit 01 01 cash flow hedge 00 00 00 02 01 00 01 04 deferred tax asset total 33 12 12 00 03 37 deferred tax liability depreciation difference untaxed reserve 60 09 01 68 pension asset 00 00 00 acquisition 98 02 96 01 08 00 02 05 deferred tax liability total 158 17 00 05 169 offset deferred tax asset 1 11 11 net deferred tax liability 147 17 00 00 05 158 1 deferred tax asset liability offset legally enforceable right offset current tax asset current tax liability deferred tax income tax relate fiscal authority accounting principle oriolakd business environment strategy business area case corporate governance financial statement 74 financial statement 84 event balance sheet date 9 parent company financial statement oriolakd corporation 50375 ashares converted bshares accordance section 3 article association oriolakd corporation 50375 ashares parent company income statement fa oriolakd year 2016 converted 50375 bshares conversion entered trade register 4 january 2017 conversion 55434273 ashares 126051940 bshares company total number share 181486213 total number vote 1234737400 eur thousand note 2016 2015 31 january 2017 nomination committee oriolakd presented board director recommendation proposal 2017 annual general meeting concerning operating income 1 79107 417758 composition board director follows personnel expense 2 39052 50403 number member board director would seven depreciation 3 2661 2168 present member board director anja korhonen mariette kristenson operating expense 4 87744 52819 kuisma niemelä eva nilsson bågenholm lena ridström staffan simberg anssi vanjoki would reelected operating profitloss 50350 312367 anssi vanjoki would reelected chairman board director financial income expense 5 133376 25147 profit appropriation tax 83026 337514 appropriation 6 149095 68843 income tax 7 21255 4370 net profit period 210867 401987 oriolakd business environment strategy business area case corporate governance financial statement 75 financial statement parent company balance sheet fa oriolakd year 2016 31 dec 31 dec 31 dec 31 dec eur thousand note 2016 2015 eur thousand note 2016 2015 asset equity liability noncurrent asset equity 12 intangible asset 8 share capital 1478998 1478998 intangible right 137359 25688 fund 194187 194187 capitalised longterm expenditure 10789 4392 invested unrestricted equity reserve 769575 769575 intangible asset total 148148 30080 retained earnings 2487967 2322720 profit financial year 210867 401987 property plant equipment 9 equity total 5141595 5167468 land water area 774 1492 machinery equipment 3511 4158 appropriation 13 1997 1093 tangible asset 75 75 tangible asset total 4360 5724 liability 14 longterm liability investment 10 borrowing 823423 652919 share group company 6553348 6095988 longterm liability 26869 receivables group company 1404540 1502417 liability group company 665572 822447 investment total 7957887 7598405 accrued liability 3088 15945 longterm liability total 1518952 1491311 noncurrent asset total 8110396 7634210 shortterm liability current asset trade payable 13105 11414 receivables liability group company 2251336 2019149 longterm liability 257439 364806 deferred tax asset 707 21961 accrued liability 17061 27823 shortterm shortterm liability total 2538941 2423191 trade receivables 11 15 receivables group company 11 502043 237738 liability total 4057893 3914502 receivables 5491 3985 accrued receivables 11 4257 4809 equity liability total 9201485 9083063 receivables total 512513 268493 cash cash equivalent 578576 1180360 current asset total 1091089 1448853 asset total 9201485 9083063 oriolakd business environment strategy business area case corporate governance financial statement 76 financial statement parent company cash flow statement fa oriolakd year 2016 eur thousand 2016 2015 eur thousand 2016 2015 cash flow operating activity cash flow financing activity operating profitloss 50350 69709 proceeds issuance share capital 755710 adjustment expense issuance share capital 18436 depreciation according plan 2661 2168 purchase share 1310 1134 unrealised exchange rate gainloss 32548 39729 proceeds repayment longterm borrowing 300000 400000 noncash item 23464 889 proceeds repayment shortterm borrowing 181734 242503 adjustment 18436 dividend paid return equity 235430 38605 87944 net cash flow financing activity 118474 93636 change working capital net change cash cash equivalent 601784 335539 change current receivables 61854 116302 change noninterestbearing current liability 4003 1075 cash cash equivalent beginning period 1180360 844821 65857 117377 net change cash cash equivalent 601784 335539 cash cash equivalent end period 3 578576 1180360 interest paid financial expense 45289 35074 interest received financial income 1 42037 49319 1 nterest paid group company included net cash flow operating income tax paid 102 activity net cash flow operating activity 24000 191179 2 change liability receivables group company included cash flow investing activity cash flow investing activity 3 cash cash equivalent include cash deposit investment subsidiary 430490 investment property plant equipment intangible asset 121902 22588 proceeds repayment longterm receivables net 2 81767 128042 dividend received 126849 327629 net cash flow investing activity 507310 433082 oriolakd business environment strategy business area case corporate governance financial statement 77 financial statement note parent company financial statement fa oriolakd year 2016 oriolakd corporation parent company oriolakd group domiciled espoo finland correction presentation figure previous financial year due oriolakd corporation provides administrative service group company change finnish accounting standard fa presentation parent company administrative service centralized parent company copy consolidated income statement amended comparative figure previous financial year financial statement oriolakd group available head office oriolakd revised merger profit presented extraordinary item previous financial year corporation orionintie 5 fi02200 espoo finland investorrelationsoriolakdcom moved operating income group contribution received moved accounting principle financial statement oriolakd corporation financial appropriation statement prepared euro according generally accepted accounting principle finland finnish gaap according corporate legislation financial statement presented thousand euro 1 operating income intangible property plant equipment intangible tangible asset eur thousand 2016 2015 measured historical cost less depreciation according plan planned depreciation rental income 108 227 recorded straightline basis useful life asset starting deployment service charge 74082 35385 asset operating income 4917 69 period planned depreciation follows intangible right merger profit 382076 longterm expenditure 5 year machinery equipment 510 year carrying value total 79107 417758 land water area well carrying value property plant equipment based historical cost writedowns done land water area 2 personnel tangible asset onetime impairment recorded parent company noncurrent eur thousand 2016 2015 asset expected profitability subsidiary significantly lowered cost personnel item denominated foreign currency valuation receivables liability salary bonus 31523 40849 denominated foreign currency based exchange rate quoted european pension cost 5815 7991 central bank balance sheet date resulting exchange gain loss personnel expense 1713 1564 recognised income statement exchange gain loss related operating total 39052 50403 activity included adjustment sale purchase whereas exchange gain loss related financial item recognised financial income expense voluntary personnel expense included operating cost financial asset liability derivative financial asset liability held trading valued fair value permitted finnish accounting act chapter 5 section average number personnel 37 38 2a financial item classified loan receivables financial liability carried amortised cost salary bonus management change fair value effective portion interest rate derivative agreement president ceo member board director 9548 9335 hedge accounting made hedge cash flow directly recognised fair value reserve included equity derivative acquired hedge balance sheet item like bank 3 depreciation account loan receivables denominated foreign currency derivative made eur thousand 2016 2015 hedge cash flow hedge accounting recorded exchange gain depreciation according plan 2661 2168 loss financial item total 2661 2168 pension liability statutory pension coverage oriolakd corporation provided ilmarinen mutual pension insurance company supplementary pension coverage provided criterion applied straightline depreciation disclosed accounting principle op life assurance company ltd financial statement income tax income tax include tax based oriolakd corporation taxable depreciation asset class presented parent company note 89 profit oriolakd business environment strategy business area case corporate governance financial statement 78 financial statement 4 operating expense 6 appropriation eur thousand 2016 2015 eur thousand 2016 2015 postage telephone banking expense 1522 702 change depreciation difference 905 769 oriolakd year 2016 expense 60404 10016 group contribution 150000 69612 travelling car 2200 2440 total 149095 68843 representation 212 250 administrative consultancy service 11901 33174 7 income tax operating expense 11505 6236 eur thousand 2016 2015 total 87744 52819 change deferred tax 21255 4370 total 21255 4370 operating cost mainly cost related ownership income tax include tax based company taxable profit financial year audit cost included operating cost audit fee 411 431 tax consulting service 03 17 fee 320 1167 total 734 1614 5 financial income expense eur thousand 2016 2015 income group company dividend income group company 126849 interest financial income interest income group company 41317 80701 interest income company 385 1780 financial income 136484 106220 interest financial expense interest expense group company 8935 124 interest expense company 24640 26209 financial expense 138084 137221 total 133376 25147 financial income expense include interest income 41703 82481 interest expense 33576 26333 exchange rate gainslosses 1775 2497 oriolakd business environment strategy business area case corporate governance financial statement 79 financial statement 8 intangible asset 9 property plant equipment advance payment oriolakd year 2016 eur thousand capitalised eur thousand machinery intangible longterm construction land tangible 2016 right expenditure progress total 2016 water area equipment asset total historical cost 1 jan 1653 6753 24590 32996 historical cost 1 jan 1492 4780 75 6347 increase 7536 112542 120078 increase 1059 1059 reclassification 540 540 00 decrease 718 1538 2256 historical cost 31 dec 1653 14829 136591 153074 historical cost 31 dec 774 4301 75 5150 accumulated amortisation 1 jan 554 2361 2915 accumulated depreciation 1 jan 623 623 amortisation financial year 331 1679 2010 change cumulative depreciation accumulated amortisation 31 dec 885 4040 4925 due sale 483 483 depreciation financial year 650 650 carrying amount 31 dec 768 10789 136591 148148 accumulated depreciation 31 dec 790 790 change cumulative accelerated carrying amount 31 dec 774 3511 75 4360 amortisation 1 jan 00 283 283 increase decrease change cumulative accelerated accelerated amortisation 00 698 698 amortisation 1 jan 809 809 cumulative accelerated increase decrease amortisation 31 dec 00 981 981 accelerated amortisation 207 207 cumulative accelerated 2015 amortisation 31 dec 1016 1016 historical cost 1 jan 1435 5896 7331 increase 218 856 24590 25664 2015 historical cost 31 dec 1653 6753 24590 32995 historical cost 1 jan 1492 2453 75 4020 increase 3513 3513 accumulated amortisation 1 jan 260 1110 1370 decrease 1186 1186 amortisation financial year 294 1251 1545 historical cost 31 dec 1492 4780 75 6347 accumulated amortisation 31 dec 554 2361 2915 accumulated depreciation 1 jan 359 359 carrying amount 31 dec 1099 4392 24590 30080 change cumulative depreciation due sale 359 359 change cumulative accelerated depreciation financial year 624 624 amortisation 1 jan 00 69 69 accumulated depreciation 31 dec 623 623 increase decrease accelerated amortisation 00 214 214 carrying amount 31 dec 1492 4158 75 5724 cumulative accelerated amortisation 31 dec 00 283 283 change cumulative accelerated amortisation 1 jan 255 255 increase decrease accelerated amortisation 555 555 cumulative accelerated amortisation 31 dec 809 809 oriolakd business environment strategy business area case corporate governance financial statement 80 financial statement 10 investment 12 equity eur thousand eur thousand 2016 2015 share receivables share capital 1 jan 1478998 1478998 oriolakd year 2016 group group share 2016 company company receivables total share capital 31 dec 1478998 1478998 historical cost 1 jan 6095988 15024169 7598405 contingency fund 1 jan 194187 194187 increase 459986 66001 525987 contingency fund 31 dec 194187 194187 decrease 2627 163878 166505 historical cost 31 dec 6553347 1404540 7957887 invested unrestricted equity reserve 1 jan 769575 13866 issue share 755710 carrying amount 31 dec 6553347 1404540 7957887 invested unrestricted equity reserve 31 dec 769575 769575 2015 profitloss previous year 1 jan 2724708 2323855 historical cost 1 jan 4486890 4403768 100 8890758 dividend paid 235806 increase 8241643 820513 9062156 sharebased compensation 1310 1562 decrease 6632545 3721863 100 10354507 purchase share 1 934 1134 historical cost 31 dec 6095988 1502418 00 7598406 proceeds sale share 1310 1562 profitloss previous year 31 dec 2487967 2322720 accumulated depreciation 1 jan 2918820 2918820 reversed writedowns due merger 2918820 2918820 net profit period 210867 401987 accumulated depreciation 31 dec 00 00 total 5141595 5167468 carrying amount 31 dec 6095988 1502417 00 7598405 1 share purchased share based incentive program 11 receivables split share 31 dec 2016 number share eur million eur thousand 2016 2015 serie share 20 votesshare 55484648 452 trade receivables serie b share 1 voteshare 126001565 1027 trade receivables nongroup company 15 total 181486213 1479 total 15 split share 31 dec 2015 number share eur million receivables group company serie share 20 votesshare 55484648 452 shortterm receivables serie b share 1 voteshare 126001565 1027 trade receivables 13180 6362 total 181486213 1479 receivables 338863 161734 accrued income prepaid expense 150000 69642 total 502043 237738 13 appropriation eur thousand 2016 2015 accrued receivables cumulative accelerated depreciation 1997 1093 arrangement fee relating loan 2264 2340 total 1997 1093 exchange rate profit hedge 50 365 compensation received 84 84 accrued receivables 1859 2019 total 4257 4809 oriolakd business environment strategy business area case corporate governance financial statement 81 financial statement 14 liability 15 commitment eur thousand 2016 2015 1000 eur 2016 2015 longterm liability commitment liability oriolakd year 2016 liability group company guarantee behalf company 83119 84818 longterm liability group company 665572 822447 guarantee behalf company 9690 19585 longterm liability total 92809 104404 borrowing 823423 652919 longterm liability 26869 accrued liability 3088 15945 longterm liability total 1518952 1491311 16 derivative financial risk management eur thousand 2016 2015 shortterm liability liability group company book value derivative instrument received prepayment 87 interest rate swap 544360 565863 trade payable 2015 2379 foreign currency forward swap 73279 00 interestbearing liability 2249321 2016668 total 617639 565863 accrued liability 15 shortterm liability fair value derivative instrument trade payable 13105 11414 interest rate swap 9063 15945 noninterestbearing liability 2848 2453 foreign currency forward swap 45 12827 interestbearing liability 254590 362352 total 9018 28772 accrued liability 17061 27823 oriolakd oyj interest rate swap agreement hedging oriolakd group cash flow well shortterm liability total 2538941 2423191 foreign currency forward swap contract various counterparties derivative managed accordance treasury policy approved oriolakd oyj board liability total 4057893 3914502 director oriolakd group interest rate risk oriola ab selling trade receivables hedged derivative agreement group level hedging present material item included accrued liability interest rate risk oriolakd oyj longterm accrued liability information oriolakd group financial risk management presented note change fair value interest rate swap 3088 15945 consolidated financial statement note financial risk management information shortterm accrued liability derivative presented note derivative item related personnel 8488 8414 derivative measured fair value 13192 interest 1939 4710 17 ownership company accrued liability 659 1506 parent company ownership company presented note group company change fair value interest rate swap 5975 relatedparty transaction note consolidated financial statement total 20149 43767 shortterm liability include liability group company 2251336 2019149 noninterestbearing liability company 33014 41690 interestbearing liability company 254590 362352 total 2538941 2423191 oriolakd business environment strategy business area case corporate governance financial statement 82 financial statement roposal profit distribution signature board director report 10 p financial statement auditor note oriolakd year 2016 proposal profit distribution auditor note parent company distributable asset balance sheet date 31 december 2016 auditor report issued today eur 36625970864 profit period eur 2108671103 espoo 10 february 2017 board director propose annual general meeting distributable fund used follows pricewaterhousecoopers oy dividend eur 014 per share distributed 181389391 share eur 2539451474 authorised public accountant eur 34086519390 retained equity material change financial position company end financial year ylva eriksson authorised public accountant signature financial statement report board director espoo 10 february 2017 anssi vanjoki eva nilsson bågenholm chairman vice chairman anja korhonen mariette kristenson kuisma niemelä lena ridström matti rihko staffan simberg eero hautaniemi president ceo oriolakd business environment strategy business area case corporate governance financial statement 83 financial statement 11 auditor report translation finnish original annual general meeting oriolakd corporation audit approach oriolakd year 2016 report audit financial statement overview opinion materiality opinion overall group materiality 45 million materiality consolidated financial statement give true fair view financial position financial performance cash flow group accordance international group audit scope financial reporting standard ifrs adopted eu group audit scope includes significant company finland financial statement give true fair view parent company financial perfor sweden covering vast majority revenue asset group scoping mance financial position accordance law regulation governing liability preparation financial statement finland comply statutory requirement key audit matter audit audited key audit revenue recognition matter audited financial statement oriolakd corporation business id 19992150 goodwill year ended 31 december 2016 financial statement comprise inventory consolidated statement financial position statement comprehensive income business acquisition statement change equity statement cash flow note consolidated financial statement include summary significant accounting policy part designing audit determined materiality assessed risk material parent company balance sheet income statement cash flow statement note misstatement financial statement particular considered management financial statement made subjective judgement example respect significant accounting estimate involved making assumption considering future event inherently uncertain basis opinion conducted audit accordance good auditing practice finland responsibil materiality ities good auditing practice described auditor responsibility scope audit influenced application materiality audit designed audit financial statement section report obtain reasonable assurance whether financial statement free material believe audit evidence obtained sufficient appropriate misstatement misstatement may arise due fraud error considered material provide basis opinion individually aggregate could reasonably expected influence economic decision user taken basis financial statement independence based professional judgement determined certain quantitative threshold independent parent company group accordance ethical materiality including overall group materiality consolidated financial statement requirement relevant audit financial statement finland set table together qualitative consideration helped u fulfilled ethical responsibility accordance requirement determine scope audit nature timing extent audit procedure evaluate effect misstatement financial statement whole oriolakd business environment strategy business area case corporate governance financial statement 84 financial statement overall group materiality oriolakd year 2016 45 million key audit matter audit group key audit matter audit group revenue recognition determined net sale profit tax testing revenue stream included refer note 42 consolidated financial statement testing company control well rationale materiality chose combination net sale substantive audit procedure benchmark applied profit tax benchmark group different revenue stream view performance oriolakd group consumer service healthcare segment testing company control focused commonly measured using criterion control around contract cash generally accepted benchmark given different nature revenue stream management consider related risk profile different substantive testing revenue transaction tailored group audit scope service segment revenue recognised included among thing following tailored scope audit taking account structure group gross basis group owns inventory performed analytical audit procedure accounting process control industry group operates principal contract pharmaceu assess whether sale margin level performed group audit 5 legal entity finland sweden addition tical company based consignment inventory line expected level agency agreement distribution performed analytical procedure remaining reporting unit sweden estonia latvia fee recognised within net sale revenue tested sample sale transaction lithuania validate revenue recognized recognition method applied requires manage correct period ment judgement analysis accounting key audit matter implication different contractual term revenue service segment exam accordingly considered key audit ined sample contract ensure revenue key audit matter matter professional judgment matter audit recognized accordance term significance audit financial statement current period matter contract group accounting policy addressed context audit financial statement whole forming accounting revenue consumer included assessing appropriateness healthcare segment include lower audit risk opinion thereon provide separate opinion matter recognition revenue gross net basis due revenue consisting multiple small audit also addressed risk management override internal transaction low degree complexity revenue consumer healthcare control including among matter consideration whether evidence bias segment matched incoming cash represented risk material misstatement due fraud recorded revenue transaction oriolakd business environment strategy business area case corporate governance financial statement 85 financial statement oriolakd year 2016 key audit matter audit group key audit matter audit group key audit matter audit group key audit matter audit group goodwill inventory refer note 532 consolidated financial audit focused assessing appropriate refer note 432 consolidated financial audit consisted testing company statement ness management judgment estimate statement control valuation existence used goodwill impairment analysis inventory well substantive audit procedure 31 december 2016 group goodwill following procedure net inventory amount 1994 million balance amounted 2869 million tested methodology applied end 2016 inventory measured lower reviewed new contract ensure recognized three reporting segment consumer value use calculation comparing cost estimated net realisable value stock accounted inventory 2252 million service 337 million requirement ia 36 impairment asset consignment basis line term healthcare 280 million tested mathematical accuracy service segment different contract group accounting policy management calculation contractual arrangement place pharmaceu company test goodwill potential tical company whereby term condition addition audit procedure included impairment annually whenever tested key underlying assumption determine whether group acting principal participated physical inventory indication carrying value may impaired evaluating process future agent distribution pharmaceutical counting selected location obtain audit comparing recoverable amount cash flow forecast drawn including product pharmacy whether product evidence regarding existence condition carrying value goodwill comparing latest board approved held stock accounted good stock inventory budget inventory consignment basis counting assessed appropriateness recoverable amount cash generating counting procedure performed discount rate long term growth rate unit determined using value use inventory key audit matter audit independent test count applied within model assessed method inherent uncertainty involved due significance asset group pwc business valuation specialist including checked obsolescence provision preparing forecast discounted future cash consolidated statement financial position comparison economic peer group calculated based group accounting flow projection assumption used due impact contractual term forecast policy group goodwill impairment model include supplier service segment estimate set note 532 compared current year actual result used computer assisted audit technique corresponding forecast included obtain audit evidence valuation inventory valuation goodwill key audit matter prior year impairment model corroborate audit due size goodwill balance reliability management estimate high level management judgement involved assessment value use considered whether sensitivity analysis performed management around key parameter cash flow forecast appropriate considering likelihood movement key assumption also assessed whether disclosure note 532 presented group assumption relation goodwill impairment sensitivity outcome impairment assessment appropriately reflected risk inherent valuation goodwill oriolakd business environment strategy business area case corporate governance financial statement 86 financial statement auditor responsibility audit financial statement oriolakd year 2016 key audit matter audit group key audit matter audit group business acquisition objective obtain reasonable assurance whether financial statement refer note 721 consolidated financial procedure assess accounting treatment whole free material misstatement whether due fraud error issue statement acquisition included auditor report includes opinion reasonable assurance high level assurance read sale purchase agreement guarantee audit conducted accordance good auditing practice 2016 oriolakd acquired swedish understand key term condition always detect material misstatement exists misstatement arise fraud company svensk do ab finnish company confirmed understanding transaction pharmaservice oy reported within error considered material individually aggregate could reasonably management healthcare segment addition group expected influence economic decision user taken basis financial acquired finnish farenta oy group evaluated recognition contingent statement reported within service segment total consideration included purchase price consideration amount 525 million intan assessing probability achieving growth profitability target set contractual part audit accordance good auditing practice exercise professional judgment gible asset goodwill recognized amounted 76 million 451 million respectively term maintain professional skepticism throughout audit also identify assess risk material misstatement financial statement whether evaluated management process ifrs 3 business combination requires group due fraud error design perform audit procedure responsive risk identifying asset liability acquired recognize identifiable asset liability obtain audit evidence sufficient appropriate provide basis opinion acquisition contingent liability fair value date acquisition excess acquisition cost risk detecting material misstatement resulting fraud higher engaged valuation specialist assist identified value recognised goodwill audit purchase price allocation one resulting error fraud may involve collusion forgery intentional omission business acquisition key audit matter including identification valuation misrepresentation override internal control audit includes significant amount intangible asset acquired obtain understanding internal control relevant audit order design audit management estimation particularly relation procedure appropriate circumstance purpose expressing identification valuation intangible asset assessed appropriateness fair value assignment useful life measurement useful life acquired opinion effectiveness parent company group internal control net asset evaluate appropriateness accounting policy used reasonableness also assessed whether disclosure note accounting estimate related disclosure made management 721 presented relevant fair information conclude appropriateness board director managing director acquisition use going concern basis accounting based audit evidence obtained whether material uncertainty exists related event condition may cast signif icant doubt parent company group ability continue going concern responsibility board director managing director conclude material uncertainty exists required draw attention financial statement auditor report related disclosure financial statement disclosure board director managing director responsible preparation inadequate modify opinion conclusion based audit evidence consolidated financial statement give true fair view accordance obtained date auditor report however future event condition may international financial reporting standard ifrs adopted eu well cause parent company group cease continue going concern preparation financial statement give true fair view accordance law evaluate overall presentation structure content financial statement regulation governing preparation financial statement finland comply including disclosure whether financial statement represent underlying statutory requirement board director managing director also transaction event manner achieves fair presentation responsible internal control determine necessary enable preparation obtain sufficient appropriate audit evidence regarding financial information financial statement free material misstatement whether due fraud error entity business activity within group express opinion consolidated preparing financial statement board director managing director financial statement responsible direction supervision performance responsible assessing group ability continue going concern disclosing group audit remain solely responsible audit opinion applicable matter related going concern using going concern basis accounting unless either intend liquidate group cease operation realistic alternative oriolakd business environment strategy business area case corporate governance financial statement 87 financial statement communicate charged governance regarding among matter opinion oriolakd year 2016 planned scope timing audit significant audit finding including significant information report board director consistent information deficiency internal control identify audit financial statement also provide charged governance statement complied report board director prepared accordance applicable relevant ethical requirement regarding independence communicate legal requirement relationship matter may reasonably thought bear independence applicable related safeguard based work performed information obtained prior matter communicated charged governance determine date auditor report conclude material misstatement matter significance audit financial statement current information required report fact nothing report regard period therefore key audit matter describe matter auditor report unless law regulation precludes public disclosure matter helsinki 1022017 extremely rare circumstance determine matter communicated pricewaterhousecoopers oy report adverse consequence would reasonably expected authorised public accountant outweigh public interest benefit communication reporting requirement ylva eriksson authorised public accountant information board director managing director responsible information information comprises information included report board director annual report include financial statement auditor report thereon obtained report board director prior date auditor report annual report expected made available u date auditor report opinion financial statement cover information connection audit financial statement responsibility read information identified consider whether information materially inconsistent financial statement knowledge obtained audit otherwise appears materially misstated respect report board director responsibility also includes considering whether report board director prepared accordance applicable legal requirement oriolakd business environment strategy business area case corporate governance financial statement 88 financial statement 12 corporate governance statement 2016 corporate governance statement prepared accordance finnish general meeting shareholder oriolakd year 2016 corporate governance code 2015 chapter 7 section 7 finnish security market act general meeting shareholder decides matter company act statement part report board director article association oriolakd within purview shareholder entitled oriolakd corporation hereinafter oriolakd company complies provi attend general meeting class share carry 20 vote class b share one vote sion article association finnish company act finnish security market general meeting according article association shareholder may vote using act similar legislation company also complies rule regulation amount vote exceeds 120 total number vote carried share applying listed company issued nasdaq helsinki ltd helsinki exchange different share class represented general meeting finnish financial supervisory authority company head office located espoo finland board director convenes general meeting shareholder notice general oriolakd applies finnish corporate governance code exception meeting published company website one daily newspaper finland capital company nomination committee may also member member city earlier two month later twenty one day prior meeting company board director exception explained section oriolakd also publishes notice general meeting stock exchange release nomination committee information required finnish corporate governance code document submitted general meeting draft resolution general also available company website wwworiolakdcom unofficial english translation meeting also available company website notice general meeting finnish corporate governance code 2015 public domain available contains proposed agenda meeting security market association website wwwcgfinlandfi shareholder right matter company act fall within oriolakd prepares consolidated financial statement interim report accordance competence general meeting dealt general meeting shareholder euapproved ifrs reporting standard security market act applicable demand writing board director well advance meeting financial supervisory authority standard rule issued nasdaq helsinki ltd matter included notice general meeting demand shall considered report board director parent company financial statement arrived time board director informed demand prepared accordance finnish accounting act guideline statement latest four week advance publication notice general meeting accounting board auditor report cover report board director chairman board director sufficient number member board consolidated financial statement parent company financial statement director committee president ceo auditor attend general meeting person proposed first time member board director shall governing structure oriolakd present general meeting decides election unless wellfounded reason absence shareholdersmeeting elect general meeting shareholder elect submits auditor shareholder shall based law article association exercise power report nomination decision general meeting annual general meeting held end may board director proposes board committee composition remuneration year duty annual general meeting include audit committee auditor adoption financial statement compensation committee elect use profit shown balance sheet elect election member board director decision fee supervises control discharging liability member board director president internal audit report ceo election auditor decision compensation ceo proposal made board director shareholder annual general meeting eg amendment article association repurchase company share risk management share issue giving special authorization cfo group management team steering croup consumer business area service business area healthcare business area oriolakd business environment strategy business area case corporate governance financial statement 89 financial statement annual general meeting 2016 nomination committee recommendation board board proposal annual general meeting oriolakd held 14 march 2016 adopted financial composition remuneration board given notice annual general statement discharged member board director president ceo meeting biographical detail proposed board member presented oriolakd year 2016 liability financial year ending 31 december 2015 according decision company website annual general meeting dividend eur 013 per share paid basis balance board director convenes accordance timetable agreed advance also sheet adopted financial year ending 31 december 2015 convenes required addition making decision board director also receives annual general meeting authorised board decide share issue meeting current information operation finance risk group payment one issue including right issue new share assign share board meeting also attended president ceo cfo general counsel held company authorisation cover combined maximum 5650000 class act secretary board member group management team attend board share 12500000 class b share company includes right derogate meeting invitation board minute kept meeting shareholder preemptive subscription right authorisation force 18 month following decision annual general meeting main task board director board also authorised decide share issue payment class b share main task dealt board director listed board rule company one issue including right issue new class b share procedure accordingly among others assign class b treasury share held company authorisation cover combined approving company strategy maximum 18000000 class b share company including right derogate approving financial target budget major investment risk management principle shareholder preemptive subscription right authorisation force maximum appointment dismissal company president ceo 18 month following decision annual general meeting consideration decision significant matter concerning operation group annual general meeting authorised board decide repurchasing business segment 18000000 company class b share share may repurchased also approving charter audit committee compensation committee proportion share owned shareholder authorisation nomination committee force maximum 18 month following decision annual general meeting annual general meeting resolved amend following article company diversity board director article association accordance proposal board director age limit ultimate goal electing member board director ensure board board member elect removed 5 possibility deliver notice director collegium competence profile support oriolakds existing annual general meeting publishing notice company website added 12 future business diversity support overall goal board director decision annual general meeting 2016 available company website optimal competence profile support company business viewed integral wwworiolakdcom part success factor enabling achievement oriolakds strategic goal important factor diversity oriolakds board director mutually complementary board director expertise member education experience different professional area board director responsible administration company industrial sector business various stage development leadership experience well appropriate organisation operation personal capacity diversity board director supported experience board director responsible managing supervising company opera operating environment industry relevant company well different culture tions accordance law governmental regulation article association consideration age gender breakdown member board also ensures good corporate governance complied throughout oriolakds board director approved diversity policy board director oriolakd group december 2016 according diversity policy board director oriolakds member board director elected general meeting shareholder objective maintain appropriate balance representation gender board director us highest decision making power oriolakd group board director general meeting shareholder pursuant article association company upheld requirement set diversity composition board board director consists fewer five eight member term director oriolakds board director 2016 represents diversity related nationality member board director expires end next annual general meeting professional competency gender following election chairman board director elected general meeting shareholder vice chairman board elected board director among member oriolakd business environment strategy business area case corporate governance financial statement 90 financial statement board director 20162017 annual general meeting oriolakd held 14 march 2016 confirmed board director oriolakd shall eight member elected following person oriolakd year 2016 chairman member board director member oriolakds board director 1 january 14 march 2016 attendance attendance year education board attendance year education board attendance name birth independence meeting committee meeting name birth independence meeting committee meeting anssi vanjoki 1956 msc 1313 jukka alho 1952 msc eng 33 compensation chairman economics independent committee 11 independent member member board board per båtelson 1950 msc physic 33 compensation anja korhonen 1953 msc 1113 audit committee 66 independent committee 11 economics member independent board member board mariette kristenson 1977 msc 810 compensation board director evaluated independence member determined economics committee 33 independent member independent company major shareholder board also member conducted assesment activity working practises board 2016 board director oriolakd convened 13 time 4 conference kuisma niemelä 1958 msc 1213 audit committee 66 call meeting 2 per capsulam meeting independent member board committee board eva nilsson bågenholm 1960 physician 1213 compensation board director audit committee compensation committee addition vice chairman independent committee 44 company nomination committee committee charter confirmed member board committee preparatory body submit proposal board matter board within purview minute kept committee meeting committee report lena ridström 1965 msc 810 compensation board regular interval committee independent decisionmaking economics committee 33 power task submit recommendation board matter consideration independent member constitutive meeting held annual general meeting board director board appoints among member member chairman audit committee matti rihko 1962 msc 1213 compensation compensation committee process appointing member nomination economics committee 34 committee presented section nomination committee msc addition audit compensation nomination committee board director psychology independent may appoint ad hoc committee preparing specific matter committee member boardapproved charter board release information term compo board sition number meeting member attendance rate staffan simberg 1949 mba 1213 audit committee 66 independent member board constitutive meeting held later day board director elected eva nilsson bågenholm vice chairman oriolakd business environment strategy business area case corporate governance financial statement 91 financial statement audit committee nomination committee task audit committee enhance control company operation nomination committee oriolakd body established board director financial reporting according charter following particular shall addressed purpose preparing presenting board recommendation proposal oriolakd year 2016 prepared audit committee put board annual general meeting concerning composition reviewing consolidated financial statement interim report together remuneration board board approved charter nomination committee auditor committee member appointed board director also appoints one reviewing together auditor deficiency supervision system observed member chairman term office committee member expire year control inspection deficiency reported auditor following appointment upon appointment committee member pursuant reviewing deficiency control system observed internal audit charter member committee need member board director observation recommendation made purpose deviation corporate governance code allow appointment reviewing plan action control inspection internal audit giving major shareholder company nomination committee thus ensure recommendation company management focus area internal audit opinion heard well annual general meeting evaluating appropriateness supervision company administration risk prior appointing committee member chairman board arranges meeting management reviewing change principle company accounting external chairman invite company twenty largest shareholder vote registered reporting prior introduction 31 august preceding annual general meeting shareholder company shareholder register maintained euroclear finland ltd purpose meeting addition audit committee duty include preparatory work decision hear major shareholder view composition committee electing auditor evaluation independence auditor taking account later 1 february preceding annual general meeting committee particularly effect provision related service independence carrying present board recommendation proposal put annual task assigned board audit committee least three general meeting concerning composition remuneration board member nomination committee evaluates independence proposed board member 14 march 2016 chairman audit committee anja korhonen recommended committee recommendation affect board independent member kuisma niemelä staffan simberg member audit committee decisionmaking authority right put proposal general meeting independent company major shareholder nomination committee appointed term office ending appointment new committee member appointment 23 september 2016 convened 5 time compensation committee attendance rate committee member 88 per cent according charter compensation committee review management personnel 23 september 2016 board director elected following person remuneration policy issue related management appointment make proposal nomination committee peter immonen timo leino mikko mursula pekka pajamo matter board director committee responsibility include ylppö pekka pajamo elected chairman committee member reviewing evaluating making proposal remuneration structure incentive committee independent company scheme management personnel oriolakd group monitoring effectiveness system ensure incentive scheme president ceo deputy ceo management promote achievement company short term long term goal board director appoints president ceo oriolakd decides term reviewing preparing matter relating remuneration management hisher employment current president ceo company eero hautaniemi personnel submitting proposal board msc econ born 1965 accordance company act president ceo considering preparing appointment top management decided board responsible day day executive management company accordance instruction order given board director addition president ceo compensation committee four member 14 march 2016 chairman also ensures account company complies finnish law financial committee eva nilsson bågenholm member mariette kristenson lena affair arranged reliable manner term condition president ridström matti rihko member compensation committee independent ceo employment specified written service contract approved board company major shareholder board director also appoints necessary deputy ceo company deputy ceo kimmo virtanen executive vice president service business msc econ born 1968 oriolakd business environment strategy business area case corporate governance financial statement 92 financial statement group management team statement standard upholding principle concerning financial reporting distributing group management team consists president ceo oriolakd chairman information business unit person appointed board end year 2016 group management team oriolakd year 2016 consisted seven member including president ceo group measurement followup management team member report performance group monitored group management team monthly group management team meet regularly address matter concerning entire report well monthly operational review business segment financial group group management team decisionmaking body assist president situation group also monitored meeting board director audit ceo implementation group strategy operational management committee board director examine interim report financial statement facilitates groupwide distribution information concerning entire group publication monitoring monthly report also ensures effectiveness internal supervision business segment must ensure effective supervision following person member oriola kds group management team 2016 operation part grouplevel internal supervision business segment group finance organisation responsible evaluation process covering financial eero hautaniemi president ceo reporting evaluation must contain balance analysis compared sari aitokallio cfo budget assessment various economic indicator stig tornell vice president consumer business 12 april 2016 thomas gawell vice president healthcare business internal control jukka mäkelä vice president development internal control form essential part company governance management teija silver vice president human resource system cover group function organisational level purpose internal kimmo virtanen executive vice president service business control ensure sufficient certainty company able carry strategy internal control separate process procedural measure covering groupwide lars birkeland vice president consumer business 12 april 2016 operating principle guideline system purpose oriolakds internal supervision system support implementation risk management internal supervision system connected group strategy ensure rule regulation observed company financial reporting internal supervision based group structure group operation internal control risk management system related oriolakds financial reporting organised business area group function group function issue grouplevel aim ensure reasonable certainty reliability company financial statement guideline laying operational framework person responsible financial reporting well company compliance legislation generally process guideline cover area accounting reporting financing investment approved accounting principle business principle guideline aim ensure risk connected achievement company financial reporting objective identified prevented control measure cover group level board director president ceo overall responsibility organising function new instruction guideline published company internal internal control risk management system pertaining financial reporting website staff member provide feedback management anonymously president ceo member group management team head report questionable activity company intranet business unit responsible accounting administration area within sphere responsibility complying legislation group operating principle risk management guideline instruction issued oriolakds board director organising board director oriolakd approves company risk management policy leading financial reporting group centralized subordination risk management operating model principle responsibility reporting specified cfo board guide supervises planning implementation risk management oriolakd group follows international financial reporting standard ifrs approved boardappointed audit committee supervises risk management group application within european union instruction accountancy principle financial oriolakd specified company risk management model principle organization reporting collected accounting manual updated soon standard change process risk management policy group risk management seek identify well financial department instruction followed group company measure manage risk may adverse beneficial impact oriolakds group accounting responsible following keeping date financial operation achievement set goal additionally group code conduct policy treasury policy covering compliance financial risk oriolakds risk oriolakd business environment strategy business area case corporate governance financial statement 93 financial statement classified strategic operational financial risk assessment management key without delay three working day execution transaction latest element strategic planning operation daily decision making company guideline set trade restriction prohibiting management person participate risk management significant risk described company website preparation interim annual financial statement oriolakd making oriolakd year 2016 wwworiolakdcom transaction company security financial instrument related closed period 30 day financial report oriolakd made public closed period internal audit oriolakd obliged draw insider list keep uptodate oriolakd us outsourced internal audit function purpose fulfilling internal time oriolakd determined include person permanent insider audit requirement outsourced internal audit function independent objective consequently person inside information included eventbased insider list assurance activity reporting directly audit committee board director relevant insider project oriolakd instructs person entered eventbased insider internal audit assignment carried basis internal audit charter approved list obligation possible consequence addition oriolakd monitor board director well internal audit plan annually reviewed approved supervises proper management insider issue audit committee related party transaction external audit oriolakds related party include management close family member well company one auditor must firm authorised public accountant company individual mentioned alone jointly others exercise control auditor elected annually annual general meeting term expires oriolakd assesses monitor transaction made related party ensure end next annual general meeting following election task auditor potential conflict interest adequately taken account company decision audit consolidated financial statement financial statement parent making oriolakd maintains list party related company company accounting group parent company administration management company confirmed 2016 neither related parent company company auditor submits auditor report shareholder party engaged business transaction oriolakd year question connection annual financial statement required law submits regular report observation board audit committee board director audit committee responsible monitoring independence auditor reason company implemented policy covering provision nonaudit service elected auditor annual general meeting oriolakd held 14 march 2016 reelected pricewaterhousecoopers oy firm authorised public accountant company auditor ylva eriksson apa principal auditor fee statutory audit paid auditing firm pricewaterhousecoopers oy 2016 totalled eur 316536 addition eur 36350 paid consultation provided group company insider management oriolakd complies insider holding guideline issued nasdaq helsinki ltd july 3 2016 market abuse regulation 5962014 mar oriolakd issued insider guideline guideline based applicable eu finnish legislation especially mar security market act 7462012 insider guideline nasdaq helsinki ltd regulation guideline european security market authority finnish financial supervisory authority member company board director ceo deputy member group management team operational responsibility leading business area company well cfo vp development information management considered management company management management related party shall notify transaction company security financial instrument made account company finnish financial supervisory authority oriolakd business environment strategy business area case corporate governance financial statement 94 financial statement remuneration statement remuneration statement published accordance corporate governance policy issue related management appointment make proposal oriolakd year 2016 code 2015 matter board director committee responsibility include reviewing evaluating making proposal remuneration structure incentive remuneration benefit member board director scheme management personnel oriolakd group annual general meeting decides annually remuneration payable member monitoring effectiveness system ensure incentive scheme board director term office nomination committee oriolakd management promote achievement company short term long term goal prepares present board recommendation proposal put board reviewing preparing matter relating remuneration management annual general meeting concerning composition remuneration board personnel submitting proposal board 14 march 2016 annual general meeting decided chairman board considering preparing appointment top management decided board receive eur 48400 remuneration term office vice chairman board chairman board audit committee eur 30250 member board director review decides annually remuneration benefit board eur 24200 chairman board receive attendance fee eur president ceo member group management team 1000 per meeting board member eur 500 per meeting attendance fee underlying criterion thereof also paid correspondingly chairman member board company board director decides annually earnings criterion determination committee travel expense paid accordance travel policy company performance bonus based proposal compensation committee accordance decision annual general meeting 60 per cent annual company granted loan president ceo member remuneration paid cash 40 per cent class b share oriolakd corporation class group management team given guarantee behalf company share b share acquired market board member follows anssi vanjoki 4404 option scheme place president ceo member group management share anja korhonen 2752 share mariette kristenson 2202 share kuisma niemelä 2202 team supplementary pension scheme except vice president consumer business share eva nilsson bågenholm 2752 share lena ridström 2202 share matti rihko 2202 vice president healthcare business defined contribution pension benefit share staffan simberg 2202 share typically applied swedish market restriction period included remuneration paid oriolakd corporation class b share member board director received sharebased right short term performance bonus remuneration included company share incentive scheme company performance bonus based achievement company financial target granted loan board member given guarantee behalf personal target maximum performance bonus 2016 president ceo 75 total fee benefit board member 2016 shareholding per cent annual salary group management team member 40 per company 31 december 2016 available remuneration report cent annual salary board director decides annually earnings criterion determination performance bonus based proposal compensation main principle decisionmaking process remuneration committee president ceo executive salary president ceo member group management team long term share based incentive scheme consists fixed base salary fringe benefit short term performance bonus long member oriolakds group management team company long term share term share incentive plan remuneration commits management develop company incentive scheme scheme unites objective shareholder key personnel financial success long term development stage strategy company increase value company commits key personnel company offer key considered determining principle remuneration personnel competitive remuneration system based ownership share company accordance charter approved board director compensation board director oriolakd approved term condition key committee monitor effectiveness incentive scheme ensure scheme employee share saving plan 28 may 2013 total 40 key employee promote achievement company short term long term goal according participating plan saving period 20142015 charter compensation committee review management personnel remuneration oriolakd business environment strategy business area case corporate governance financial statement 95 financial statement 15 june 2015 board director decided launch third saving period 20152016 financial benefit president ceo 2016 approximately 50 group key employee enrolled saving period ended 31 salary remuneration including fringe benefit paid 2016 president december 2016 holding period end publication date oriolakd q42017 ceo eero hautaniemi amounted total eur 658927 follows oriolakd year 2016 interim report fixed base salary eur 467206 19 october 2016 board director decided launch fourth saving period 2017 fringe benefit eur 28537 targeted approximately 90 group key employee saving period last 12 month performance bonus eur 148743 ending 31 december 2017 holding period end publication date sharebased payment eur 14441 oriolakd q42018 interim report board director resolved establish new sharebased incentive plan directed president ceo sixmonth period notice entitled severance pay group key personnel plan 4 december 2015 aim plan combine equal 12 month salary retirement age president ceo 63 year objective shareholder key personnel order increase value pension accordance employee pension act president ceo included company longterm retain key personnel company offer company share based incentive scheme shareholding president ceo competitive reward plan based performance accumulation share ownership company available remuneration report company aim also harmonize company incentive plan oneplatform plan company key personnel share saving plan longterm incentive plan financial benefit executive 2016 combined salary remuneration including fringe benefit paid 2016 member plan includes three performance period calendar year 2016 2017 2018 three group management team totalled eur 1819758 follows vesting period calendar year 2017 2018 2019 respectively board director fixed base salary totalling eur 1511968 company resolve plan performance criterion required performance fringe benefit totalling eur 81486 level criterion beginning performance period approximately 20 key performance bonus totalling eur 200547 person including member group management team belong target group sharebased payment totalling eur 25757 plan prerequisite participation plan receipt reward basis member group management team included company share based plan key person enrolled share saving plan make monthly saving incentive scheme shareholding member group management team fixed gross monthly salary accordance rule share saving company available remuneration report plan force potential reward performance period 2016 based group earnings per share eps reward paid basis performance period 2016 corresponded value approximate maximum total 800000 oriolakd corporation class b share including also proportion paid cash potential reward paid partly oriolakd corporation class b share partly cash 2018 cash proportion intended cover tax taxrelated cost arising reward key person potential reward performance period 2017 based group earnings per share eps reward paid basis performance period 2017 corresponded value approximate maximum total 800000 oriolakd corporation class b share including also proportion paid cash potential reward paid partly oriolakd corporation class b share partly cash 2019 cash proportion intended cover tax taxrelated cost arising reward key person oriolakd business environment strategy business area case corporate governance financial statement 96 financial statement remuneration report salary benefit member board director ceo member group management team 2016 shareholding including controlled entity 31122016 oriolakd year 2016 salary salary shareholding benefit 2016 benefit 2015 31122016 teur teur share b share total board director vanjoki anssi chairman 594 599 9160 9160 nilsson bågenholm eva vice chairman 388 302 5130 5130 korhonen anja 408 437 11754 11754 kristenson mariette 297 2202 2202 niemelä kuisma 322 338 9491 9491 ridström lena 297 2202 2202 rihko matti 307 318 10970 10970 simberg staffan 322 322 2202 2202 nezinvest ab 152378 152378 alho jukka 15 413 båtelson per 10 303 brade harry 28 president ceo hautaniemi eero fixed basic salary 4672 4179 246497 246497 fringe benefit 285 249 performance bonus 1487 1475 sharebased payment 144 374 total 6589 6277 group management team stig tornell 6142 6142 sari aitokallio 2573 2573 jukka mäkelä 10321 10321 teija silver 33910 33910 kimmo virtanen 1757 121553 123310 thomas gawell 20400 20400 lars birkeland 1242016 salary benefit group management 18198 16560 oriolakd business environment strategy business area case corporate governance financial statement 97 information shareholder 2017 annual general meeting oriolakd year 2016 2017 annual general meeting shareholder oriolakd corporation held tuesday 14 march 2017at 2 pm helsinki exhibition convention centre address helsinki exhibition convention centre conference wing rautatieläisenkatu 3 00520 helsinki finland notice convene published company website wwworiolakdcom 16 february 2017 shareholder register insider register company shareholder register available euroclear finland ltd following address euroclear finland ltd urho kekkosen katu 5 c fi00100 helsinki finland shareholder requested make change address account operator attends shareholder bookentry account analyst following oriolakd bank investment service company listed published investment report oriolakd coporation analyst contact detail listed oriolakd website carnegie investment bank danske market evli bank plc inderes ltd nordea market pohjola bank plc oriolakd business environment strategy business area case corporate governance financial statement oriolakd corporation orionintie 5 po box 8 fi02101 espoo finland wwworiolakdcom